Media Center

 

Portfolio News Archives

« Back to Current News

Editas Medicine
March 16, 2017 - Editas Medicine, Inc. Announces Pricing of $90 Million Offering of Common Stock
» Press Release | Company News

Editas Medicine
March 15, 2017 - Editas Medicine, Inc., Announces Proposed Offering of Common Stock
» Press Release | Company News

Voyager Therapeutics
March 15, 2017 - Voyager Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Corporate Highlights
» Press Release | Company News

Editas Medicine
March 14, 2017 - Allergan and Editas Medicine Enter into Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing Medicines for Eye Diseases
» Press Release | Company News

Agios Pharmaceuticals
March 13, 2017 - Agios Announces MTAP Pathway Research Program as Development Program and Development Candidate Under Master Research and Collaboration Agreement with Celgene
» Press Release | Company News

Global Blood Therapeutics
March 13, 2017 - Global Blood Therapeutics Reports Recent Business Progress and Fourth Quarter and Year-End 2016 Financial Results
» Press Release | Company News

Myokardia
March 13, 2017 - MyoKardia Reports Fourth Quarter and Full Year 2016 Financial Results and Operational Progress
» Press Release | Company News

Jounce Therapeutics
March 10, 2017 - Jounce Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results
» Press Release | Company News

Blueprint Medicines
March 9, 2017 - Blueprint Medicines Reports Fourth Quarter and Full Year 2016 Financial Results
» Press Release | Company News

Zafgen
March 9, 2017 - Zafgen Reports Fourth Quarter and Full Year 2016 Financial Results
» Press Release | Company News

Voyager Therapeutics
March 8, 2017 - Voyager Therapeutics to Host Fourth Quarter and Full Year 2016 Financial Results Conference call
» Press Release | Company News

Editas Medicine
March 7, 2017 - Editas Medicine Announces Fourth Quarter and Full Year 2016 Results and Update
» Press Release | Company News

Editas Medicine
March 3, 2017 - Editas Medicine Announces Departure of Chief Operating Officer
» Press Release | Company News

Allena Pharmaceuticals
March 3, 2017 - Allena Pharmaceuticals to Present at The Cowen And Company 37th Annual Health Care Conference
» Press Release | Company News

Blueprint Medicines
March 2, 2017 - Blueprint Medicines to Report Fourth Quarter and Full Year 2016 Financial Results on Thursday, March 9, 2017
» Press Release | Company News

CytomX Therapeutics
March 2, 2017 - CytomX Announces Full-Year 2016 Financial Results
» Press Release | Company News

Foundation Medicine
March 2, 2017 - Foundation Medicine Receives Medicare Payment in Non-Small Cell Lung Cancer under a Local Coverage Determination for FoundationOne®, the Company's Comprehensive Genomic Profiling Assay
» Press Release | Company News

SAGE Therapeutics
March 2, 2017 - Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
» Press Release | Company News

Zafgen
March 2, 2017 - Zafgen to Host Conference Call to Discuss Fourth Quarter and Full Year 2016 Financial Results
» Press Release | Company News

Agios Pharmaceuticals
March 1, 2017 - FDA Accepts New Drug Application and Grants Priority Review for Enasidenib in Relapsed or Refractory AML with an IDH2 Mutation
» Press Release | Company News

bluebird bio
March 1, 2017 - bluebird bio Announces Publication of Case Study on First Patient with Severe Sickle Cell Disease Treated with Gene Therapy in The New England Journal of Medicine
» Press Release | Company News

CytomX Therapeutics
March 1, 2017 - CytomX Therapeutics to Announce Full-Year 2016 Financial Results
» Press Release | Company News

Eleven Biotherapeutics
March 1, 2017 - Eleven Biotherapeutics to Present at Upcoming Investor Conferences in March
» Press Release | Company News

Global Blood Therapeutics
March 1, 2017 - Global Blood Therapeutics Announces Participation at Two Upcoming Investor Conferences in March
» Press Release | Company News

Agios Pharmaceuticals
February 28, 2017 - Agios to Present at the Cowen and Company 37th Annual Health Care Conference on Monday, March 6, 2017
» Press Release | Company News

bluebird bio
February 28, 2017 - bluebird bio to Present at Two Investor Conferences in March
» Press Release | Company News

Blueprint Medicines
February 28, 2017 - Blueprint Medicines to Present at Upcoming Investor Conferences in March
» Press Release | Company News

Editas Medicine
February 28, 2017 - Editas Medicine Joins Global Movement to Raise Awareness on Rare Disease Day 2017
» Press Release | Company News

Editas Medicine
February 28, 2017 - Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2016 Corporate Update and Results
» Press Release | Company News

Foundation Medicine
February 28, 2017 - Foundation Medicine to Present at Cowen and Company's 37th Annual Healthcare Conference
» Press Release | Company News

Jounce Therapeutics
February 28, 2017 - Jounce Therapeutics to Present at Cowen and Company 37th Annual Health Care Conference
» Press Release | Company News

Myokardia
February 28, 2017 - MyoKardia to Present at Cowen and Company 37th Annual Health Care Conference
» Press Release | Company News

Voyager Therapeutics
February 28, 2017 - Voyager Therapeutics Supports Rare Disease Day® and Global Movement to Raise Awareness for Rare Diseases
» Press Release | Company News

Zafgen
February 28, 2017 - Zafgen to Present at Upcoming Investor Conferences
» Press Release | Company News

Editas Medicine
February 27, 2017 - Editas Medicine to Present at Investor Conferences in March
» Press Release | Company News

Global Blood Therapeutics
February 27, 2017 - Global Blood Therapeutics Announces Closing of Public Offering of Common Stock Including Full Exercise of Option to Purchase Additional Shares
» Press Release | Company News

SAGE Therapeutics
February 23, 2017 - Sage Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update
» Press Release | Company News

Seventh Sense BioSystems
February 23, 2017 - First-Ever Device for Fast and Virtually Painless Blood Draw Receives FDA Clearance
» Press Release | Company News

bluebird bio
February 22, 2017 - bluebird bio Reports Fourth Quarter and Full Year 2016 Financial Results and Recent Operational Progress
» Press Release | Company News

Foundation Medicine
February 22, 2017 - Foundation Medicine Announces 2016 Fourth Quarter and Year-End Results, Recent Highlights and 2017 Outlook
» Press Release | Company News

Global Blood Therapeutics
February 22, 2017 - Global Blood Therapeutics Prices a $125.0 Million Upsized Common Stock Public Offering
» Press Release | Company News

CytomX Therapeutics
February 21, 2017 - CytomX Therapeutics to Present at Upcoming Investor Conferences
» Press Release | Company News

Global Blood Therapeutics
February 21, 2017 - Global Blood Therapeutics Announces Proposed Public Offering of Common Stock
» Press Release | Company News

Neon Therapeutics
February 21, 2017 - Using Mono-allelic Mass Spectrometry Data to Improve Epitope Prediction Algorithms Published in Immunity
» Press Release | Company News

SAGE Therapeutics
February 17, 2017 - Sage Therapeutics to Report Fourth Quarter and Full Year 2016 Financial Results on Thursday, February 23, 2017
» Press Release | Company News

Agios Pharmaceuticals
February 16, 2017 - Agios Reports Fourth Quarter and Full Year 2016 Financial Results and Highlights Key 2017 Milestones
» Press Release | Company News

Global Blood Therapeutics
February 16, 2017 - Global Blood Therapeutics Announces Initiation of Phase 1 Trial to Evaluate the Physiologic Effects of GBT440 in Healthy Volunteers Under Hypoxemic Conditions
» Press Release | Company News

Rhythm
February 16, 2017 - Rhythm Announces Completion of $41 Million Mezzanine Financing
» Press Release | Company News

SAGE Therapeutics
February 16, 2017 - Sage Therapeutics Not in M&A Discussions: STATEMENT
» Press Release | Company News

Blueprint Medicines
February 15, 2017 - Blueprint Medicines to Present at 2017 RBC Capital Markets Global Healthcare Conference
» Press Release | Company News

Editas Medicine
February 15, 2017 - Editas Medicine Announces U.S. Patent and Trademark Office Decision Favorable to Broad Institute in CRISPR Interference
» Press Release | Company News

Ablexis
February 14, 2017 - Ablexis Announces Perpetual License Agreement for AlivaMab Mouse with Janssen
» Press Release | Company News

Global Blood Therapeutics
February 14, 2017 - Global Blood Therapeutics Announces Publication of Paper Describing Discovery of GBT440 in ACS Medicinal Chemistry Letters
» Press Release | Company News

Decibel Therapeutics
February 13, 2017 - Decibel Therapeutics Presents at 2017 Annual Association for Research in Otolaryngology (ARO) Meeting
» Press Release | Company News

SAGE Therapeutics
February 13, 2017 - Sage Therapeutics Advances SAGE-217 into Placebo-Controlled Phase 2 Clinical Trial in Major Depressive Disorder
» Press Release | Company News

Voyager Therapeutics
February 13, 2017 - Voyager Therapeutics Announces Lead Clinical Candidate Selection for Monogenic Form of Amyotrophic Lateral Sclerosis (ALS)
» Press Release | Company News

Editas Medicine
February 10, 2017 - Editas Medicine to Present at Upcoming February Investor Conferences
» Press Release | Company News

Agios Pharmaceuticals
February 9, 2017 - Agios to Webcast Conference Call of Fourth Quarter and Full Year 2016 Financial Results on February 16, 2017
» Press Release | Company News

Goldfinch Bio
February 9, 2017 - Goldfinch Bio Appoints Nephrologist Louis Brenner, M.D., M.B.A. to Board of Directors
» Press Release | Company News

Zafgen
February 9, 2017 - Zafgen to Present at the Leerink Partners 6th Annual Global Healthcare Conference
» Press Release | Company News

Eleven Biotherapeutics
February 7, 2017 - Eleven Biotherapeutics to Present at the 2017 BIO CEO & Investor Conference
» Press Release | Company News

Fulcrum Therapeutics
February 7, 2017 - Fulcrum Therapeutics Strengthens its Board of Directors with the Addition of Alan Ezekowitz, MBChB, D.Phil., and James J. Collins, Ph.D.
» Press Release | Company News

SAGE Therapeutics
February 7, 2017 - Sage Therapeutics to Participate in Upcoming February Investor Conferences
» Press Release | Company News

Foundation Medicine
February 6, 2017 - Foundation Medicine Announces Timing for Fourth Quarter and Year-End 2016 Financial Results and Conference Call
» Press Release | Company News

bluebird bio
February 3, 2017 - bluebird bio Announces First Patient Treated with LentiGlobin™ Drug Product Under Amended Study Protocol in HGB-206 Phase 1 Study of Patients with Severe Sickle Cell Disease
» Press Release | Company News

CytomX Therapeutics
February 2, 2017 - CytomX Announces the First Patient Treated in Phase 1/2 PROCLAIM-072 Trial
» Press Release | Company News

CytomX Therapeutics
February 2, 2017 - CytomX to Present at Upcoming Investor Conferences
» Press Release | Company News

Myokardia
February 2, 2017 - First Subjects Dosed in MyoKardia Phase 1 Study of Dilated Cardiomyopathy Candidate MYK-491
» Press Release | Company News

Voyager Therapeutics
February 2, 2017 - Voyager Therapeutics to Attend Upcoming Investor Conferences
» Press Release | Company News

Myokardia
February 1, 2017 - MyoKardia Announces Appointment of June Lee, M.D., as Chief Operating Officer and Radhika Tripuraneni, M.D., as Vice President, Medical Affairs
» Press Release | Company News

Jounce Therapeutics
January 26, 2017 - Jounce Therapeutics Announces Pricing of Initial Public Offering
» Press Release | Company News

Voyager Therapeutics
January 25, 2017 - Voyager Therapeutics Announces Publication of Vectored Anti-Tau Monoclonal Antibody Study in The Journal of Neuroscience
» Press Release | Company News

Voyager Therapeutics
January 20, 2017 - Voyager Therapeutics Announces Updates from Phase 1b Trial of VY-AADC01 for Advanced Parkinson’s Disease
» Press Release | Company News

Global Blood Therapeutics
January 18, 2017 - Global Blood Therapeutics Announces Enrollment of First Patient in Phase 3 HOPE Study in Sickle Cell Disease
» Press Release | Company News

Decibel Therapeutics
January 18, 2017 - Decibel Therapeutics Expands Leadership Team With World-Class Bioinformatics Scientist; Appoints Three New Members to its Board of Directors
» Press Release | Company News

Agios Pharmaceuticals
January 9, 2017 - Agios Announces Key Upcoming Milestones to Support Evolution to a Commercial Stage Biopharmaceutical Company in 2017
» Press Release | Company News

CytomX Therapeutics
January 9, 2017 - CytomX to Present at the 35th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

CytomX Therapeutics
January 9, 2017 - UPDATE: CytomX Announces Time Change for its Presentation at the 35th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Editas Medicine
January 9, 2017 - Editas Medicine Reports on Recent Progress and 2017 Goals at J.P. Morgan Healthcare Conference
» Press Release | Company News

Foundation Medicine
January 9, 2017 - Foundation Medicine Reports Preliminary 2016 Results
» Press Release | Company News

Foundation Medicine
January 6, 2017 - Foundation Medicine Announces Executive Leadership Transition
» Press Release | Company News

Kala Pharmaceuticals
January 6, 2017 - Kala Pharmaceuticals to Present Update on Phase 3 Programs at the 35th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Taris Biomedial
January 6, 2017 - TARIS Biomedical® Announces Positive Results from Ph1b Trial of TAR-200 (GemRIS™) in Patients with Muscle Invasive Bladder Cancer
» Press Release | Company News

Allena Pharmaceuticals
January 5, 2017 - Allena Pharmaceuticals To Present At The 35th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Neon Therapeutics
January 5, 2017 - Neon Therapeutics Secures $70 Million in Series B Financing
» Press Release | Company News

Pliant Therapeutics
January 5, 2017 - Pliant Therapeutics Appoints Leading Academic Researcher and Industry Veteran Rik Derynck, Ph.D. As Scientific Founder
» Press Release | Company News

Voyager Therapeutics
January 5, 2017 - Voyager Therapeutics Elects Wendy Dixon, Ph.D. and Glenn Pierce, M.D., Ph.D. to Board of Directors
» Press Release | Company News

bluebird bio
January 4, 2017 - bluebird bio to Present at the 35th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Editas Medicine
January 4, 2017 - Editas Medicine to Present at the 35th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Agios Pharmaceuticals
January 3, 2017 - Agios to Present at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017
» Press Release | Company News

Agios Pharmaceuticals
January 3, 2017 - Agios Appoints Ian Clark to Board of Directors
» Press Release | Company News

Foundation Medicine
January 3, 2017 - Foundation Medicine to Present at the 35th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Global Blood Therapeutics
January 3, 2017 - Global Blood Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Myokardia
January 3, 2017 - MyoKardia Announces Advancement to Next Phase of Global Collaboration with Sanofi
» Press Release | Company News

SAGE Therapeutics
January 3, 2017 - Sage Therapeutics to Present at J.P. Morgan Healthcare Conference on Tuesday, January 10, 2017
» Press Release | Company News

Voyager Therapeutics
January 3, 2017 - Voyager Therapeutics Appoints Jane Pritchett Henderson as Chief Financial Officer
» Press Release | Company News

SAGE Therapeutics
December 29, 2016 - Sage Therapeutics to Participate in Goldman Sachs Healthcare Conference
» Press Release | Company News

Neon Therapeutics
December 28, 2016 - Neon Therapeutics to Present at 35th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

REVOLUTION Medicines
December 20, 2016 - REVOLUTION Medicines Raises Additional $25 Million in Series A Financing
» Press Release | Company News

Editas Medicine
December 19, 2016 - Editas Medicine Extends CRISPR Genome Editing Leadership Through Licensing of New CRISPR Technologies
» Press Release | Company News

Foundation Medicine
December 19, 2016 - Foundation Medicine Receives FDA Approval of FoundationFocus™ CDxBRCA as a Companion Diagnostic for Rubraca™ (rucaparib) for the Treatment of Women with Ovarian Cancer
» Press Release | Company News

SAGE Therapeutics
December 19, 2016 - Sage Therapeutics Announces Initiation of Phase 2 Clinical Development for SAGE-217 in Mood Disorders
» Press Release | Company News

Global Blood Therapeutics
December 16, 2016 - Global Blood Therapeutics Added to NASDAQ Biotechnology Index
» Press Release | Company News

Agios Pharmaceuticals
December 15, 2016 - Agios Provides Update on PKR Program
» Press Release | Company News

bluebird bio
December 15, 2016 - bluebird bio and apceth Biopharma Establish Commercial Drug Product Manufacturing Agreement
» Press Release | Company News

Goldfinch Bio
December 14, 2016 - Third Rock Ventures launches Goldfinch Bio with $55M in Series A funding to bring precision medicine to patients with kidney disease
» Press Release | Company News

bluebird bio
December 14, 2016 - bluebird bio Announces First Patient Treated with LentiGlobin Drug Product in Northstar-2 (HGB-207) Phase 3 Trial of Patients with Transfusion-Dependent β-Thalassemia
» Press Release | Company News

CytomX Therapeutics
December 14, 2016 - CytomX Announces U.S. FDA Clearance of Investigational New Drug Application for Phase 1/2 Clinical Study of Anti-PD-L1 Probody Therapeutic, CX-072
» Press Release | Company News

CytomX Therapeutics
December 13, 2016 - CytomX Announces Selection by Bristol-Myers Squibb of First Clinical Candidate Probody From Collaboration
» Press Release | Company News

REVOLUTION Medicines
December 13, 2016 - REVOLUTION Medicines Names Distinguished Cancer Scientists and Drug Hunters to Senior Advisory Roles
» Press Release | Company News

SAGE Therapeutics
December 13, 2016 - Sage Therapeutics Announces Initiation of Phase 2 Clinical Development for SAGE-217 in Movement Disorders
» Press Release | Company News

Voyager Therapeutics
December 9, 2016 - Voyager Therapeutics to Attend Upcoming Investor Conference
» Press Release | Company News

Myokardia
December 8, 2016 - MyoKardia to Present at 2016 BMO Capital Markets Healthcare Conference
» Press Release | Company News

Blueprint Medicines
December 7, 2016 - Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock
» Press Release | Company News

Fulcrum Therapeutics
December 7, 2016 - Fulcrum Therapeutics Appoints Renowned Experts in CNS Disorders and Muscular Dystrophies to Serve on Newly Formed Scientific Advisory Board
» Press Release | Company News

SAGE Therapeutics
December 7, 2016 - Sage Therapeutics to Webcast R&D Day on December 13, 2016
» Press Release | Company News

Voyager Therapeutics
December 7, 2016 - Voyager Therapeutics Announces Positive Interim Results from Phase 1b Trial of VY-AADC01 for Advanced Parkinson’s Disease
» Press Release | Company News

bluebird bio
December 6, 2016 - bluebird bio Announces Proposed Public Offering of Common Stock
» Press Release | Company News

bluebird bio
December 6, 2016 - bluebird bio Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

Blueprint Medicines
December 6, 2016 - Blueprint Medicines Announces Proposed Public Offering of Shares of Common Stock
» Press Release | Company News

Nurix, Inc.
December 6, 2016 - Nurix Appoints Robert Tjian, Ph.D. of The Column Group to its Board of Directors
» Press Release | Company News

SAGE Therapeutics
December 6, 2016 - Sage Announces Expedited Development Plan for SAGE-547 in the Treatment of Postpartum Depression based on FDA Breakthrough Therapy Meeting
» Press Release | Company News

Agios Pharmaceuticals
December 5, 2016 - Agios Announces New Clinical Data from Dose-Escalation Portion of Phase 1 Trial of Single Agent AG-120 Showing Durable Molecular Responses in Patients with Advanced Hematologic Malignancies
» Press Release | Company News

bluebird bio
December 5, 2016 - bluebird bio Provides Updates on HSC Gene Therapy Programs
» Press Release | Company News

CytomX Therapeutics
December 5, 2016 - CytomX Announces Fourth Target Selection by Bristol-Myers Squibb Under Strategic Oncology Collaboration
» Press Release | Company News

Global Blood Therapeutics
December 5, 2016 - Global Blood Therapeutics Announces New Details on its Novel Patient Reported Outcomes (PRO) Tool to be used in Phase 3 HOPE Study
» Press Release | Company News

Agios Pharmaceuticals
December 4, 2016 - Agios Announces New Data from AG-348 and AG-519 Demonstrating Potential for First Disease-modifying Treatment for Patients with PK Deficiency
» Press Release | Company News

Blueprint Medicines
December 4, 2016 - Blueprint Medicines Announces Proof-of-Concept Data from Phase 1 Clinical Trial of BLU-285 in Patients with Advanced Systemic Mastocytosis
» Press Release | Company News

Global Blood Therapeutics
December 4, 2016 - Global Blood Therapeutics Announces New Long-Term Clinical Data from Ongoing Phase 1/2 Trial of GBT440 in Sickle Cell Disease at ASH
» Press Release | Company News

bluebird bio
December 3, 2016 - bluebird bio Presents New Data from HGB-205 Study of LentiGlobin™ Drug Product in Patients with Transfusion-Dependent β-Thalassemia (TDT) and Severe Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting
» Press Release | Company News

bluebird bio
December 2, 2016 - bluebird bio Announces Management Appointments
» Press Release | Company News

Myokardia
December 2, 2016 - MyoKardia Announces Receipt of Milestone Payment from Sanofi for DCM Candidate MYK-491
» Press Release | Company News

Magenta Therapeutics
December 2, 2016 - Magenta Therapeutics Cofounder David Scadden Honored at the American Society of Hematology Annual Meeting, as Scientific Founders Present New Stem Cell Biology Data
» Press Release | Company News

Myokardia
December 1, 2016 - MyoKardia Announces Appointment of Marc Semigran, M.D., as Chief Medical Officer
» Press Release | Company News

SAGE Therapeutics
December 1, 2016 - Sage Therapeutics to Present at American Epilepsy Society 70th Annual Meeting
» Press Release | Company News

bluebird bio
November 30, 2016 - bluebird bio Announces Interim Phase 1 Dose Escalation Data for its Anti-BCMA CAR T Product Candidate in Patients with Relapsed/Refractory Multiple Myeloma
» Press Release | Company News

Blueprint Medicines
November 30, 2016 - Blueprint Medicines Announces Proof-of-Concept Data from Phase 1 Clinical Trial of BLU-285 in Patients with Advanced Gastrointestinal Stromal Tumors
» Press Release | Company News

Global Blood Therapeutics
November 30, 2016 - Global Blood Therapeutics Announces GBT440 Granted Orphan Drug Designation in Europe for Treatment of Sickle Cell Disease
» Press Release | Company News

Global Blood Therapeutics
November 30, 2016 - Global Blood Therapeutics Announces Upcoming Investor Webcast to Review GBT440 Data Being Presented at ASH that Support Sickle Cell Disease Program
» Press Release | Company News

Voyager Therapeutics
November 29, 2016 - Voyager Therapeutics and REGENXBIO Announce Exercise of Options for Rights to NAV Vectors
» Press Release | Company News

Warp Drive Bio
November 29, 2016 - Warp Drive Bio Achieves Key Milestone in Antibiotics Collaboration with Sanofi
» Press Release | Company News

Blueprint Medicines
November 28, 2016 - Blueprint Medicines Announces Proof-of-Concept Data from Global Phase 1 Clinical Trial of BLU-554 in Patients with Advanced Hepatocellular Carcinoma
» Press Release | Company News

Global Blood Therapeutics
November 28, 2016 - Global Blood Therapeutics Announces Initiation of Phase 2a Trial of GBT440 in Idiopathic Pulmonary Fibrosis (IPF)
» Press Release | Company News

Seventh Sense BioSystems
November 18, 2016 - Seventh Sense Biosystems Raises Series C Round of Funding
» Press Release | Company News

Agios Pharmaceuticals
November 18, 2016 - Agios Announces Phase 1 Data from Dose Expansion Cohorts of AG-120 in Patients with IDH1 Mutant Positive Glioma and Chondrosarcoma
» Press Release | Company News

Neon Therapeutics
November 17, 2016 - Neon Therapeutics Announces First Patient Enrolled in Inaugural Clinical Trial for Personalized Cancer Vaccine NEO-PV-01
» Press Release | Company News

Corvia Medical
November 16, 2016 - Corvia Medical Announces Strong Positive One-Year Data from Reduce LAP-HF Clinical Study
» Press Release | Company News

Magenta Therapeutics
November 16, 2016 - Magenta Therapeutics Announces $48.5M Series A Financing to Transform Stem Cell Transplant for Immune and Blood Diseases
» Press Release | Company News

SAGE Therapeutics
November 16, 2016 - SAGE-547 Granted PRIME Designation by EMA for the Treatment of Postpartum Depression
» Press Release | Company News

Blueprint Medicines
November 15, 2016 - Blueprint Medicines to Present Preliminary Data from Ongoing Phase 1 Clinical Trials for BLU-285 and BLU-554 at 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
» Press Release | Company News

Ninepoint Medical
November 15, 2016 - NinePoint Medical Announces Substantial Hospital Reimbursement Increase for Procedures Using the NvisionVLE® Imaging System with Real-time Targeting™
» Press Release | Company News

bluebird bio
November 14, 2016 - bluebird bio to Present New Data from Novel Anti-BCMA CAR T Cell Therapy bb2121 at EORTC-NCI-AACR Molecular Targets and Cancer Therapies Symposium
» Press Release | Company News

Blueprint Medicines
November 14, 2016 - Blueprint Medicines Announces Appointment of Marion Dorsch, Ph.D. as Chief Scientific Officer and the Transition of Christoph Lengauer, Ph.D., MBA, to a Newly Created Executive Vice President Role
» Press Release | Company News

Eleven Biotherapeutics
November 14, 2016 - Eleven Biotherapeutics Reports Third Quarter 2016 Financial Results
» Press Release | Company News

Myokardia
November 11, 2016 - MyoKardia Announces Exploratory Digital Health Substudy as Part of PIONEER-HCM Trial of MYK-461 in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients
» Press Release | Company News

Blueprint Medicines
November 10, 2016 - Blueprint Medicines Reports Third Quarter 2016 Financial Results
» Press Release | Company News

SAGE Therapeutics
November 10, 2016 - Sage Therapeutics to Present at Society for Neuroscience 2016 Annual Meeting
» Press Release | Company News

Voyager Therapeutics
November 10, 2016 - Voyager Therapeutics Provides Third Quarter 2016 Investor Update
» Press Release | Company News

CytomX Therapeutics
November 9, 2016 - CytomX to Present at the Jefferies 2016 London Healthcare Conference
» Press Release | Company News

Editas Medicine
November 9, 2016 - Editas Medicine to Present at the Stifel Healthcare Conference 2016
» Press Release | Company News

Global Blood Therapeutics
November 9, 2016 - Global Blood Therapeutics Reports Recent Business Progress and Provides Third Quarter 2016 Financial Results
» Press Release | Company News

SAGE Therapeutics
November 9, 2016 - Sage Therapeutics to Present at the Stifel 2016 Healthcare Conference
» Press Release | Company News

Zafgen
November 9, 2016 - Zafgen Reports Third Quarter 2016 Financial Results
» Press Release | Company News

Editas Medicine
November 7, 2016 - Editas Medicine Announces Third Quarter 2016 Results and Update
» Press Release | Company News

Myokardia
November 7, 2016 - MyoKardia Reports Progress on Clinical Programs and Third Quarter 2016 Financial Results
» Press Release | Company News

Neon Therapeutics
November 7, 2016 - Neon Therapeutics Appoints Dr. Richard Gaynor to President of Research and Development
» Press Release | Company News

Myokardia
November 4, 2016 - MyoKardia Announces Presentations at American Heart Association Scientific Sessions 2016
» Press Release | Company News

Rhythm
November 4, 2016 - Rhythm Presents Positive Initial Data for Setmelanotide in LepR Deficiency Obesity
» Press Release | Company News

Agios Pharmaceuticals
November 3, 2016 - Agios Reports Third Quarter 2016 Financial Results and Reviews Recent Progress in IDH and PKR Development Programs
» Press Release | Company News

Agios Pharmaceuticals
November 3, 2016 - Agios to Present New Data from PKR and IDH Programs at the 2016 ASH Annual Meeting
» Press Release | Company News

bluebird bio
November 3, 2016 - bluebird bio to Present New Data from Three LentiGlobinTM Clinical Studies at American Society of Hematology (ASH) Annual Meeting
» Press Release | Company News

Blueprint Medicines
November 3, 2016 - Blueprint Medicines to Present Preliminary Data from Ongoing Phase 1 Clinical Trial for BLU-285 in Advanced Systemic Mastocytosis at 2016 ASH Annual Meeting
» Press Release | Company News

Blueprint Medicines
November 3, 2016 - Blueprint Medicines to Report Third Quarter 2016 Financial Results on Thursday, November 10, 2016
» Press Release | Company News

CytomX Therapeutics
November 3, 2016 - CytomX Therapeutics Announces Third Quarter 2016 Financial Results and Provides Pipeline Update
» Press Release | Company News

Foundation Medicine
November 3, 2016 - Flatiron Health and Foundation Medicine Unveil Powerful Oncology Information Resource to Advance Precision Medicine
» Press Release | Company News

Global Blood Therapeutics
November 3, 2016 - Global Blood Therapeutics Announces Upcoming Presentation of Data Supporting Sickle Cell Disease Program at the 58th American Society of Hematology (ASH) Annual Meeting & Exposition Conference
» Press Release | Company News

SAGE Therapeutics
November 3, 2016 - Sage Therapeutics Announces Third Quarter 2016 Financial Results and Provides SRSE European Update
» Press Release | Company News

bluebird bio
November 2, 2016 - bluebird bio Reports Third Quarter 2016 Financial Results and Recent Operational Progress
» Press Release | Company News

Foundation Medicine
November 2, 2016 - Foundation Medicine Announces 2016 Third Quarter Results and Recent Highlights
» Press Release | Company News

Myokardia
November 2, 2016 - MyoKardia Announces Dosing of First Patient in Phase 2 PIONEER-HCM Study of MYK-461 in Symptomatic, Obstructive Hypertrophic Cardiomyopathy
» Press Release | Company News

Agios Pharmaceuticals
November 1, 2016 - Agios to Present at the 25th Annual Credit Suisse Healthcare Conference Tuesday, November 8, 2016
» Press Release | Company News

bluebird bio
November 1, 2016 - bluebird bio to Present at Two Investor Conferences in November
» Press Release | Company News

Decibel Therapeutics
November 1, 2016 - Decibel Therapeutics Assembles World-Class Scientific Advisory Board
» Press Release | Company News

Voyager Therapeutics
November 1, 2016 - Voyager Therapeutics to Host Third Quarter 2016 Investor Update Call
» Press Release | Company News

Editas Medicine
October 31, 2016 - Editas Medicine to Host Conference Call Discussing Third Quarter 2016 Corporate Update and Results
» Press Release | Company News

Foundation Medicine
October 31, 2016 - Foundation Medicine and Sarah Cannon Collaborate to Advance Personalized Medicine for Patients with Cancer
» Press Release | Company News

Myokardia
October 31, 2016 - MyoKardia to Present at Two Upcoming Investor Conferences in November
» Press Release | Company News

Alcresta Therapeutics
October 28, 2016 - Alcresta Therapeutics’ RELiZORB™ Increases Fat Absorption in Adult and Pediatric Patients with Cystic Fibrosis Receiving Enteral Nutrition
» Press Release | Company News

Blueprint Medicines
October 28, 2016 - Blueprint Medicines to Present Preclinical Data and Provide Enrollment Updates for Phase 1 Clinical Trial for BLU-285 in Advanced Systemic Mastocytosis at ECNM Annual Meeting 2016
» Press Release | Company News

Agios Pharmaceuticals
October 27, 2016 - Agios to Webcast Conference Call of Third Quarter 2016 Financial Results on November 3, 2016
» Press Release | Company News

CytomX Therapeutics
October 27, 2016 - CytomX Therapeutics to Announce Third Quarter 2016 Financial Results
» Press Release | Company News

Foundation Medicine
October 27, 2016 - Foundation Medicine Adds Life Sciences Leader Michael R. Dougherty to its Board of Directors
» Press Release | Company News

Motus
October 27, 2016 - Allergan to Acquire GI Disease Subsidiary of Rhythm Holding Company, LLC, Expanding Innovative Gastroenterology Pipeline
» Press Release | Company News

SAGE Therapeutics
October 27, 2016 - Sage Therapeutics to Report Third Quarter 2016 Financial Results on Thursday, November 3, 2016
» Press Release | Company News

Global Blood Therapeutics
October 24, 2016 - Global Blood Therapeutics Announces Pivotal Study for GBT440 in Sickle Cell Disease with Primary Hemoglobin Endpoint
» Press Release | Company News

SAGE Therapeutics
October 20, 2016 - Sage Therapeutics and Collaborators Publish New Pre-clinical Data in Neuropharmacology Demonstrating a Novel Metabotropic Mechanism of Sage Compounds Resulting in Enhanced Effects
» Press Release | Company News

Voyager Therapeutics
October 18, 2016 - Voyager Therapeutics Announces Planned Transition Process for Chief Financial Officer
» Press Release | Company News

Editas Medicine
October 17, 2016 - Editas Medicine to Present Data on CRISPR/Cas9-mediated Gene Editing in Hematopoietic Stem/Progenitor Cells at ESGCT-ISSCR 2016
» Press Release | Company News

Warp Drive Bio
October 17, 2016 - Warp Drive Bio Appoints Steven H. Holtzman to its Board of Directors
» Press Release | Company News

Ninepoint Medical
October 15, 2016 - New Clinical Data using the NvisionVLE® Imaging System to be presented at ACG 2016 and UEGW 2016
» Press Release | Company News

bluebird bio
October 13, 2016 - bluebird bio Provides Update on LentiGlobin™ Programs and Research and Development Strategy at Gene Therapy Day
» Press Release | Company News

Foundation Medicine
October 12, 2016 - Foundation Medicine Announces Timing for Third Quarter 2016 Financial Results and Conference Call
» Press Release | Company News

Agios Pharmaceuticals
October 12, 2016 - Celgene and Agios Announce Collaborations with Abbott for Diagnostic Identification of IDH Mutations in AML
» Press Release | Company News

Global Blood Therapeutics
October 12, 2016 - Global Blood Therapeutics Announces Appointment of Tricia Suvari as Chief Legal Officer
» Press Release | Company News

Global Blood Therapeutics
October 7, 2016 - Global Blood Therapeutics Presents GBT440 Data that Continue to Support Durability, Safety and Mechanism of Action in Sickle Cell Disease
» Press Release | Company News

bluebird bio
October 6, 2016 - bluebird bio Announces Topics for Gene Therapy Day, October Investor Presentation
» Press Release | Company News

Editas Medicine
October 6, 2016 - Editas Medicine Reports Inducement Grant to New Chief Medical Officer
» Press Release | Company News

Allena Pharmaceuticals
October 4, 2016 - Allena Pharmaceuticals and Health Advances Present Analysis of Recurrent Kidney Stone Disease at the Academy of Managed Care Pharmacy Nexus Conference
» Press Release | Company News

Editas Medicine
October 3, 2016 - Editas Medicine Expands Senior Management Team
» Press Release | Company News

Editas Medicine
October 3, 2016 - Editas Medicine to Present at the Jefferies Gene Editing/Therapy Summit
» Press Release | Company News

Myokardia
October 3, 2016 - MyoKardia Announces Closing of Public Offering of Common Stock Including Full Exercise of Option to Purchase Additional Shares
» Press Release | Company News

bluebird bio
September 29, 2016 - bluebird bio and Medigene Establish Strategic T Cell Receptor (TCR) Alliance in Cancer Immunotherapy
» Press Release | Company News

Myokardia
September 27, 2016 - MyoKardia Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

Neon Therapeutics
September 27, 2016 - Neon Therapeutics Appoints Oncology Veteran Hugh O’Dowd to Chief Executive Officer
» Press Release | Company News

SAGE Therapeutics
September 27, 2016 - Sage Reports Additional Positive Data on Secondary Endpoints from Phase 2 Clinical Trial of SAGE-547 in Severe Postpartum Depression at the Marcé Society for Perinatal Mental Health Biennial Scientific Meeting
» Press Release | Company News

Jounce Therapeutics
September 26, 2016 - Jounce Therapeutics Appoints Stephen Farrand, Ph.D., to Chief Technical Officer
» Press Release | Company News

Myokardia
September 26, 2016 - MyoKardia Announces Proposed Public Offering of Common Stock
» Press Release | Company News

bluebird bio
September 21, 2016 - LentiGlobin™ Investigational Gene Therapy for Transfusion-Dependent Beta-Thalassemia Accepted into European Medicines Agency’s PRIME Program
» Press Release | Company News

Eleven Biotherapeutics
September 21, 2016 - Eleven Biotherapeutics Acquires Viventia Bio to Create Targeted Protein Therapeutics Oncology Company
» Press Release | Company News

Eleven Biotherapeutics
September 21, 2016 - Eleven Biotherapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
» Press Release | Company News

Myokardia
September 21, 2016 - MyoKardia Outlines Path to Registration for MYK-461 in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients and Provides Pipeline and Research Updates at Inaugural R&D Day
» Press Release | Company News

SAGE Therapeutics
September 21, 2016 - Sage Therapeutics to Present at the Leerink Partners Rare Disease Roundtable
» Press Release | Company News

Agios Pharmaceuticals
September 20, 2016 - Agios Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
» Press Release | Company News

Zafgen
September 20, 2016 - Zafgen Initiates Multiple Ascending Dose Cohorts in Phase 1 Clinical Trial of ZGN-1061
» Press Release | Company News

Fulcrum Therapeutics
September 19, 2016 - FierceBiotech names Fulcrum Therapeutics as one of its “Fierce 15” Biotech Companies of 2016
» Press Release | Company News

Neon Therapeutics
September 19, 2016 - FierceBiotech names Neon Therapeutics as one of its “Fierce 15” Biotech Companies of 2016
» Press Release | Company News

Rhythm
September 19, 2016 - FierceBiotech Names Rhythm as a “Fierce 15” Biotechnology Company of 2016
» Press Release | Company News

SAGE Therapeutics
September 16, 2016 - Sage Therapeutics to Present at the Neurocritical Care Society 14th Annual Meeting
» Press Release | Company News

Eleven Biotherapeutics
September 16, 2016 - Eleven Biotherapeutics Completes Exclusive Licensing Deal for IL-6 Antagonist Antibody Technology, Including EBI-031
» Press Release | Company News

Voyager Therapeutics
September 15, 2016 - Voyager Therapeutics Licenses Novel Gene Therapy Capsids from the California Institute of Technology
» Press Release | Company News

Agios Pharmaceuticals
September 14, 2016 - Agios Announces Pricing of $150 Million Public Offering of Common Stock
» Press Release | Company News

Relay Therapeutics
September 14, 2016 - Third Rock Ventures Launches Relay Therapeutics with $57 Million Series A Financing to Create Breakthrough Medicines Based on Protein Motion
» Press Release | Company News

Global Blood Therapeutics
September 14, 2016 - Global Blood Therapeutics Announces Publication of Preclinical Results Supporting GBT440 Program for Hypoxemic Pulmonary Disorders
» Press Release | Company News

Myokardia
September 14, 2016 - MyoKardia to Host R&D Day on September 21
» Press Release | Company News

Agios Pharmaceuticals
September 13, 2016 - Agios Announces Proposed Offering of Common Stock
» Press Release | Company News

Voyager Therapeutics
September 12, 2016 - Voyager Therapeutics and CHDI Foundation Collaborate to Develop Novel Gene Therapy for Huntington’s Disease
» Press Release | Company News

bluebird bio
September 9, 2016 - bluebird bio Announces Webcast of Gene Therapy Day
» Press Release | Company News

Blueprint Medicines
September 9, 2016 - Blueprint Medicines Announces New Drug Discovery Program Targeting PRKACA Kinase Fusions for the Treatment of Fibrolamellar Carcinoma at 10th International Liver Cancer Association (ILCA) Annual Conference
» Press Release | Company News

bluebird bio
September 8, 2016 - bluebird bio Opens Phase 3 Study of LentiGlobin™ Drug Product in Patients with Transfusion-Dependent Beta-Thalassemia
» Press Release | Company News

SAGE Therapeutics
September 8, 2016 - Sage Therapeutics Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

Allena Pharmaceuticals
September 7, 2016 - Allena Pharmaceuticals Strengthens Leadership Team, Names Edward Wholihan As Chief Financial Officer And Robert Alexander, Phd, To Board Of Directors
» Press Release | Company News

Blueprint Medicines
September 7, 2016 - Blueprint Medicines to Present at Morgan Stanley Global Healthcare Conference
» Press Release | Company News

Decibel Therapeutics
September 7, 2016 - Decibel Therapeutics Expands Leadership Team
» Press Release | Company News

Jounce Therapeutics
September 7, 2016 - Jounce Therapeutics Initiates Phase 1/2 ICONIC Study of JTX­2011 in Patients with Advanced Solid Tumors
» Press Release | Company News

SAGE Therapeutics
September 7, 2016 - Sage Therapeutics Announces Proposed Public Offering of Common Stock
» Press Release | Company News

Agios Pharmaceuticals
September 6, 2016 - Agios to Present at Morgan Stanley Global Healthcare Conference Tuesday, September 13, 2016
» Press Release | Company News

Blueprint Medicines
September 6, 2016 - Blueprint Medicines Announces Appointment of Tracey McCain as Chief Legal Officer and Executive Vice President
» Press Release | Company News

Editas Medicine
September 6, 2016 - Editas Medicine to Present at the Morgan Stanley Global Healthcare Conference
» Press Release | Company News

Foundation Medicine
September 6, 2016 - Foundation Medicine to Present at the Morgan Stanley Global Healthcare Conference
» Press Release | Company News

Global Blood Therapeutics
September 6, 2016 - Global Blood Therapeutics Joins Sickle Cell Disease (SCD) Coalition in Support of SCD Community with Goal to Improve Treatment and Care
» Press Release | Company News

SAGE Therapeutics
September 6, 2016 - Sage Receives FDA Breakthrough Therapy Designation for SAGE-547 for the Treatment of Postpartum Depression
» Press Release | Company News

Myokardia
September 1, 2016 - MyoKardia to Present at 2016 Wells Fargo Healthcare Conference
» Press Release | Company News

Global Blood Therapeutics
August 31, 2016 - Global Blood Therapeutics Announces Participation at Two Upcoming Investor Conferences in September
» Press Release | Company News

bluebird bio
August 30, 2016 - bluebird bio to Present at Four Upcoming Conferences
» Press Release | Company News

Pliant Therapeutics
August 30, 2016 - Pliant Therapeutics Appoints Suzanne Bruhn, Ph.D., to Board of Directors
» Press Release | Company News

SAGE Therapeutics
August 30, 2016 - Sage Therapeutics and Collaborators Announce Publication Highlighting Epidemiology and Burden of Illness for Super-Refractory Status Epilepticus in Journal of Medical Economics
» Press Release | Company News

Warp Drive Bio
August 30, 2016 - Warp Drive Bio Awarded Patent Covering Proprietary Method for Discovering New Medicines
» Press Release | Company News

Editas Medicine
August 22, 2016 - Editas Medicine Names Charles Albright as Chief Scientific Officer
» Press Release | Company News

Foundation Medicine
August 22, 2016 - Foundation Medicine Adds New Immunotherapy Features to Its Market-Leading Products
» Press Release | Company News

Agios Pharmaceuticals
August 16, 2016 - Agios Appoints Andrew Hirsch as Chief Financial Officer
» Press Release | Company News

Eleven Biotherapeutics
August 16, 2016 - Eleven Biotherapeutics Completes Exclusive Licensing Deal for IL-6 Antagonist Antibody Technology, Including EBI-031
» Press Release | Company News

Eleven Biotherapeutics
August 12, 2016 - Eleven Biotherapeutics Reports Second Quarter 2016 Financial Results and Provides Strategic Update
» Press Release | Company News

Voyager Therapeutics
August 12, 2016 - Voyager Therapeutics to Attend Upcoming Investor Conferences
» Press Release | Company News

Voyager Therapeutics
August 11, 2016 - Voyager Therapeutics Provides Second Quarter 2016 Investor Update
» Press Release | Company News

Global Blood Therapeutics
August 10, 2016 - Global Blood Therapeutics Reports Recent Business Progress and Provides Second Quarter 2016 Financial Results
» Press Release | Company News

Myokardia
August 10, 2016 - MyoKardia to Present at the 2016 Wedbush PacGrow Healthcare Conference
» Press Release | Company News

Taris Biomedial
August 10, 2016 - TARIS Biomedical® Launches Second Phase 1b Clinical Trial of TAR-200 (GemRISTM) in Patients with Bladder Cancer
» Press Release | Company News

Blueprint Medicines
August 9, 2016 - Blueprint Medicines Reports Second Quarter 2016 Financial Results
» Press Release | Company News

Editas Medicine
August 9, 2016 - Adverum Biotechnologies and Editas Medicine Announce Collaboration to Explore Delivery of Genome Editing Medicines to the Eye
» Press Release | Company News

Editas Medicine
August 9, 2016 - Editas Medicine Announces Second Quarter 2016 Results and Update
» Press Release | Company News

Global Blood Therapeutics
August 9, 2016 - Global Blood Therapeutics to Present at the Wedbush PacGrow Healthcare Conference
» Press Release | Company News

Myokardia
August 9, 2016 - MyoKardia Reports Second Quarter 2016 Financial Results and Continued Progress on Clinical Programs
» Press Release | Company News

SAGE Therapeutics
August 9, 2016 - Sage Therapeutics Announces Second Quarter 2016 Financial Results and Provides Corporate Update
» Press Release | Company News

Voyager Therapeutics
August 9, 2016 - Voyager Therapeutics Initiates Third Cohort in Ongoing Phase 1b Clinical Trial of VY-AADC01 in Advanced Parkinson’s Disease
» Press Release | Company News

Agios Pharmaceuticals
August 5, 2016 - Agios to Present at Canaccord Genuity 36th Annual Growth Conference Wednesday, August 10, 2016
» Press Release | Company News

Agios Pharmaceuticals
August 4, 2016 - Agios Reports Second Quarter 2016 Financial Results
» Press Release | Company News

bluebird bio
August 4, 2016 - bluebird bio to Present at Wedbush PacGrow Healthcare Conference
» Press Release | Company News

Decibel Therapeutics
August 4, 2016 - Decibel Therapeutics to Open New Headquarters and Laboratories in The Fenway
» Press Release | Company News

Voyager Therapeutics
August 4, 2016 - Voyager Therapeutics to Host Second Quarter 2016 Investor Update Call
» Press Release | Company News

Zafgen
August 4, 2016 - Zafgen Reports Second Quarter 2016 Financial Results
» Press Release | Company News

bluebird bio
August 3, 2016 - bluebird bio Reports Second Quarter 2016 Financial Results and Recent Operational Progress
» Press Release | Company News

Blueprint Medicines
August 3, 2016 - Blueprint Medicines to Present at Upcoming Investor Conferences in August
» Press Release | Company News

CytomX Therapeutics
August 3, 2016 - CytomX Announces Second Quarter 2016 Financial Results
» Press Release | Company News

Editas Medicine
August 3, 2016 - Editas Medicine Announces Exclusive License to Advanced CRISPR Genome Editing Technology from Massachusetts General Hospital
» Press Release | Company News

SAGE Therapeutics
August 3, 2016 - Sage Therapeutics to Present at the Canaccord Genuity 36th Annual Growth Conference
» Press Release | Company News

Zafgen
August 3, 2016 - Zafgen to Present at Canaccord Genuity's 36th Annual Growth Conference
» Press Release | Company News

Blueprint Medicines
August 2, 2016 - Blueprint Medicines to Report Second Quarter 2016 Financial Results on Tuesday, August 9, 2016
» Press Release | Company News

Editas Medicine
August 2, 2016 - Editas Medicine to Host Conference Call Discussing Second Quarter 2016 Corporate Update and Results
» Press Release | Company News

Foundation Medicine
August 2, 2016 - FoundationOne® Accepted by FDA and CMS for Parallel Review and FDA Expedited Access Pathway
» Press Release | Company News

Foundation Medicine
August 2, 2016 - Foundation Medicine Announces 2016 Second Quarter Results and Recent Highlights
» Press Release | Company News

SAGE Therapeutics
August 2, 2016 - Sage Therapeutics to Report Second Quarter 2016 Financial Results on Tuesday, August 9, 2016
» Press Release | Company News

Editas Medicine
July 29, 2016 - Editas Medicine Appoints Akshay Vaishnaw, M.D., Ph.D., to its Board of Directors
» Press Release | Company News

Neon Therapeutics
July 29, 2016 - Neon Therapeutics Announces FDA Acceptance of Investigational New Drug Application for Cancer Vaccine NEO­PV­01
» Press Release | Company News

Agios Pharmaceuticals
July 28, 2016 - Agios to Webcast Conference Call of Second Quarter 2016 Financial Results on August 4, 2016
» Press Release | Company News

Editas Medicine
July 28, 2016 - Editas Medicine Announces Scientific Multi-Year Collaboration with Fondazione Telethon and Ospedale San Raffaele
» Press Release | Company News

CytomX Therapeutics
July 27, 2016 - CytomX Therapeutics to Announce Second Quarter 2016 Financial Results and Provide Mid-Year Update
» Press Release | Company News

Rhythm
July 27, 2016 - Rhythm Announces “The Genetic Obesity Project” to Expand Understanding of Rare Genetic Disorders of Obesity
» Press Release | Company News

Alcresta Therapeutics
July 26, 2016 - RELiZORB™ Recognized for Medical Design Excellence
» Press Release | Company News

Ablexis
July 20, 2016 - Ablexis Announces Perpetual License of the AlivaMab Mouse to a Top 15 Pharma
» Press Release | Company News

Rhythm
July 20, 2016 - Rhythm Announces New England Journal of Medicine Publication of Setmelanotide Phase 2 Data for Treatment of POMC Deficiency Obesity
» Press Release | Company News

Fulcrum Therapeutics
July 19, 2016 - Third Rock Ventures Launches Fulcrum Therapeutics with $55 Million Series A Investment
» Press Release | Company News

Jounce Therapeutics
July 19, 2016 - Jounce Therapeutics Announces Major Strategic Collaboration with Celgene Corporation to Develop Next-generation Immuno-oncology Therapies for Patients with Cancer
» Press Release | Company News

SAGE Therapeutics
July 19, 2016 - Sage Appoints Geno Germano to Company's Board of Directors
» Press Release | Company News

Zafgen
July 19, 2016 - Zafgen Refocuses Resources on Development of Differentiated Second-Generation MetAP2 Inhibitor ZGN-1061
» Press Release | Company News

bluebird bio
July 18, 2016 - bluebird bio Presents megaTAL Genome Editing Data at American Society of Hematology (ASH) Workshop on Genome Editing
» Press Release | Company News

Myokardia
July 14, 2016 - SHaRe Registry Data Published in PNAS Demonstrate the Power of Combining Clinical, Genetic and Structural Data to Gain Insight into Hypertrophic Cardiomyopathy
» Press Release | Company News

Decibel Therapeutics
July 13, 2016 - Decibel Therapeutics Appoints Steven H. Holtzman as President and Chief Executive Officer
» Press Release | Company News

Taris Biomedial
July 13, 2016 - TARIS Biomedical® Initiates Phase 1b Clinical Trial of TAR-200 (GemRIS™) in Patients with Muscle-Invasive Bladder Cancer
» Press Release | Company News

Foundation Medicine
July 12, 2016 - Foundation Medicine Announces Timing for Second Quarter 2016 Financial Results and Conference Call
» Press Release | Company News

SAGE Therapeutics
July 12, 2016 - Sage Reports Positive Top-line Results Including Demonstration of 30-Day Durability from Phase 2 Clinical Trial of SAGE-547 in Severe Postpartum Depression
» Press Release | Company News

Jounce Therapeutics
July 11, 2016 - Jounce Therapeutics to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
» Press Release | Company News

Myokardia
July 11, 2016 - MyoKardia Announces Topline Clinical Data Supporting Advancement of MYK-461 to Phase 2 PIONEER-HCM Study in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients
» Press Release | Company News

Global Blood Therapeutics
July 8, 2016 - Global Blood Therapeutics Announces Publication of Preclinical GBT440 Results in British Journal of Haematology that Support Sickle Cell Disease (SCD) Program
» Press Release | Company News

Eleven Biotherapeutics
July 7, 2016 - Eleven Biotherapeutics Announces Effectiveness of Investigational New Drug Application for EBI-031
» Press Release | Company News

Warp Drive Bio
July 5, 2016 - Warp Drive Bio Appoints Rachel K. King to its Board of Directors
» Press Release | Company News

Foundation Medicine
June 29, 2016 - Foundation Medicine Announces Release of Molecular Information from FoundationCORE™ to the National Cancer Institute in Support of the National Cancer Moonshot and Precision Medicine Initiatives
» Press Release | Company News

Global Blood Therapeutics
June 29, 2016 - Global Blood Therapeutics Announces Initiation of Phase 2a Study of GBT440 in Adolescents with Sickle Cell Disease
» Press Release | Company News

Voyager Therapeutics
June 22, 2016 - Voyager Therapeutics Announces Interim Phase 1b Surgical Results for VY-AADC01 in Advanced Parkinson’s Disease
» Press Release | Company News

Global Blood Therapeutics
June 20, 2016 - Global Blood Therapeutics Announces Proposed Public Offering of Common Stock
» Press Release | Company News

Global Blood Therapeutics
June 20, 2016 - Global Blood Therapeutics Announces Initiation of Phase 2a Study of GBT440 in Idiopathic Pulmonary Fibrosis
» Press Release | Company News

Global Blood Therapeutics
June 20, 2016 - Global Blood Therapeutics Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

REVOLUTION Medicines
June 14, 2016 - REVOLUTION Medicines Names Academic Co-Founder, Michael Fischbach, Ph.D., and Senior Advisor, Eric Gordon, Ph.D.
» Press Release | Company News

CytomX Therapeutics
June 13, 2016 - CytomX Therapeutics Appoints John A. Scarlett, M.D., to Board of Directors
» Press Release | Company News

Eleven Biotherapeutics
June 13, 2016 - Eleven Biotherapeutics Announces Investigational New Drug Application Submission to Initiate Clinical Trials of EBI-031 for Ocular Diseases
» Press Release | Company News

Eleven Biotherapeutics
June 13, 2016 - Eleven Biotherapeutics Announces Signing of Exclusive License Agreement
» Press Release | Company News

Agios Pharmaceuticals
June 11, 2016 - AG-348 Achieves Proof-of-Concept in Ongoing Phase 2 DRIVE-PK Study and Demonstrates Rapid and Sustained Hemoglobin Increases in Adults with Pyruvate Kinase Deficiency
» Press Release | Company News

Zafgen
June 11, 2016 - Zafgen Presents New Data From The Phase 2b Clinical Trial Evaluating Beloranib In Severe Obesity Complicated By Type 2 Diabetes At The American Diabetes Association's 76th Scientific Sessions
» Press Release | Company News

Global Blood Therapeutics
June 10, 2016 - Global Blood Therapeutics Announces New Clinical Data that Continue to Support Safety and Efficacy Profile of GBT440 as a Potentially Disease-Modifying Therapy for Sickle Cell Disease
» Press Release | Company News

Afferent Pharmaceuticals
June 9, 2016 - Merck to Acquire Afferent Pharmaceuticals
» Press Release | Company News

Agios Pharmaceuticals
June 9, 2016 - Agios Reports Initial Data from Phase 1 Study of AG-519 in Healthy Volunteers
» Press Release | Company News

bluebird bio
June 9, 2016 - Lonza and bluebird bio, Inc., Establish a Long-term Commercial Manufacturing Agreement for Lenti-D™ and LentiGlobin™ Drug Products
» Press Release | Company News

Alcresta Therapeutics
June 7, 2016 - Alcresta Therapeutics Launches RELiZORB™ in the U.S.
» Press Release | Company News

SAGE Therapeutics
June 7, 2016 - Sage Reports Positive Top-line Results from Phase 1 Clinical Program of SAGE-217
» Press Release | Company News

Foundation Medicine
June 6, 2016 - Data From a Study Utilizing FoundationOne® Heme Indicates Age-Associated Genomic Profiles in Acute Myeloid Leukemia
» Press Release | Company News

Foundation Medicine
June 6, 2016 - New Data from Foundation Medicine and Collaborators Supports Use of Comprehensive Genomic Profiling to Inform Therapeutic Choices in Advanced Breast Cancer
» Press Release | Company News

Foundation Medicine
June 5, 2016 - Foundation Medicine Presents New Data at ASCO 2016 Demonstrating that FoundationOne® May Help Predict Response to Cancer Immunotherapy Across a Variety of Advanced Cancers
» Press Release | Company News

Foundation Medicine
June 4, 2016 - Foundation Medicine and AstraZeneca Enter Strategic Collaboration for Lynparza Companion Diagnostic Assay
» Press Release | Company News

Foundation Medicine
June 4, 2016 - FoundationOne® Identifies Patients with Advanced Lung Cancer Likely to Respond or Develop Resistance to Certain RET Inhibitor Therapies
» Press Release | Company News

Allena Pharmaceuticals
June 2, 2016 - Allena Pharmaceuticals to Present at the 2016 Jefferies Healthcare Conference
» Press Release | Company News

Global Blood Therapeutics
June 2, 2016 - Global Blood Therapeutics to Host Investor Event on Friday, June 10 to Review GBT440 Data in Sickle Cell Disease Being Presented at the European Hematology Association's 21st Congress
» Press Release | Company News

Agios Pharmaceuticals
June 1, 2016 - Agios to Host Conference Call from the 21st Congress of the European Hematology Association
» Press Release | Company News

Blueprint Medicines
June 1, 2016 - Blueprint Medicines to Present at Upcoming Investor Conferences in June
» Press Release | Company News

Foundation Medicine
June 1, 2016 - Foundation Medicine to Present at the Goldman Sachs Annual Healthcare Conference
» Press Release | Company News

SAGE Therapeutics
June 1, 2016 - Sage Therapeutics to Present at the Goldman Sachs 37th Annual Global Healthcare Conference
» Press Release | Company News

SAGE Therapeutics
May 26, 2016 - Sage Therapeutics Announces Completion of Enrollment for Phase 2 Proof-of-Concept Trial of SAGE-547 in Severe Postpartum Depression
» Press Release | Company News

Jounce Therapeutics
May 25, 2016 - Jounce Therapeutics Appoints Barbara G. Duncan to its Board of Directors
» Press Release | Company News

CytomX Therapeutics
May 24, 2016 - CytomX to Present at the Jefferies 2016 Healthcare Conference
» Press Release | Company News

Editas Medicine
May 24, 2016 - Editas Medicine to Present at Upcoming June Investor Conferences
» Press Release | Company News

bluebird bio
May 23, 2016 - bluebird bio to Present at Goldman Sachs 37th Annual Healthcare Conference
» Press Release | Company News

Agios Pharmaceuticals
May 19, 2016 - Agios to Present Clinical and Preclinical Data from PKR Activators AG-348 and AG-519 at the 21st Congress of the European Hematology Association
» Press Release | Company News

Global Blood Therapeutics
May 19, 2016 - Global Blood Therapeutics Announces Presentation of New GBT440 Data in Sickle Cell Disease at the European Hematology Association's 21st Congress
» Press Release | Company News

Ninepoint Medical
May 19, 2016 - NinePoint Medical Announces Completion of Clinical Registry and Publication of Results at DDW 2016
» Press Release | Company News

Afferent Pharmaceuticals
May 18, 2016 - Afferent Pharmaceuticals Reports Cardiovascular Research Showing P2X3 Antagonism Successfully Reduces Hypertension By Restoring Autonomic Nervous Balance at the 2016 American Thoracic Society Conference
» Press Release | Company News

Foundation Medicine
May 18, 2016 - Foundation Medicine Announces Presentations at ASCO
» Press Release | Company News

Global Blood Therapeutics
May 18, 2016 - Global Blood Therapeutics to Present at the UBS 2016 Global Healthcare Conference
» Press Release | Company News

Agios Pharmaceuticals
May 17, 2016 - Agios and Celgene Establish New Collaboration in Metabolic Immuno-Oncology and Amend Certain Rights from 2010 Agreement
» Press Release | Company News

Agios Pharmaceuticals
May 17, 2016 - Agios Updates 2016 Financial Guidance
» Press Release | Company News

Agios Pharmaceuticals
May 17, 2016 - Agios and Celgene Establish New Collaboration in Metabolic Immuno-Oncology and Amend Certain Rights from 2010 Agreement
» Press Release | Company News

Foundation Medicine
May 17, 2016 - Foundation Medicine Receives Patent Covering Fundamental Methods in Comprehensive Genomic Analysis in Cancer
» Press Release | Company News

Afferent Pharmaceuticals
May 16, 2016 - Afferent Pharmaceuticals Presents Updated Positive Results with AF-219 from Phase 2B Chronic Cough Study at the 2016 American Thoracic Society (ATS) International Conference
» Press Release | Company News

Editas Medicine
May 16, 2016 - Editas Medicine Announces First Quarter 2016 Results and Update
» Press Release | Company News

Editas Medicine
May 16, 2016 - Editas Medicine Announces Agreement with Cystic Fibrosis Foundation Therapeutics to Advance New CRISPR/Cas9 Medicines
» Press Release | Company News

Myokardia
May 16, 2016 - MyoKardia to Present at 2016 UBS Global Healthcare Conference
» Press Release | Company News

Global Blood Therapeutics
May 12, 2016 - Global Blood Therapeutics Reports Recent Business Progress and Provides First Quarter 2016 Financial Results
» Press Release | Company News

Myokardia
May 12, 2016 - MyoKardia Reports First Quarter 2016 Financial Results and Operational Progress
» Press Release | Company News

Voyager Therapeutics
May 12, 2016 - Voyager Therapeutics Provides First Quarter 2016 Investor Update
» Press Release | Company News

Voyager Therapeutics
May 11, 2016 - Voyager Therapeutics to Present at Upcoming Investor Conferences
» Press Release | Company News

Blueprint Medicines
May 10, 2016 - Blueprint Medicines Reports First Quarter 2016 Financial Results
» Press Release | Company News

Ninepoint Medical
May 10, 2016 - NinePoint Medical Announces FDA 510(k) Clearance of a Real-Time Targeting Feature for the NvisionVLE® Imaging System and the First Clinical Cases in the U.S.
» Press Release | Company News

Zafgen
May 10, 2016 - Zafgen Reports First Quarter 2016 Financial Results
» Press Release | Company News

bluebird bio
May 9, 2016 - bluebird bio Presents Oncology and Gene Therapy Data at the ASGCT 19th Annual Meeting
» Press Release | Company News

Editas Medicine
May 9, 2016 - Editas Medicine to Host Conference Call Discussing First Quarter 2016 Corporate Update and Results
» Press Release | Company News

CytomX Therapeutics
May 6, 2016 - CytomX Announces First Quarter 2016 Financial Results
» Press Release | Company News

Allena Pharmaceuticals
May 5, 2016 - FDA Grants Orphan Drug Designation to Allena’s Investigational Therapy for the Treatment of Pediatric Hyperoxaluria
» Press Release | Company News

Agios Pharmaceuticals
May 5, 2016 - Agios Reports First Quarter 2016 Financial Results
» Press Release | Company News

Eleven Biotherapeutics
May 5, 2016 - Eleven Biotherapeutics Reports First Quarter 2016 Financial Results
» Press Release | Company News

SAGE Therapeutics
May 5, 2016 - Sage Therapeutics Announces First Quarter 2016 Financial Results
» Press Release | Company News

Voyager Therapeutics
May 5, 2016 - Voyager Therapeutics to Host First Quarter 2016 Investor Update Call
» Press Release | Company News

bluebird bio
May 4, 2016 - bluebird bio Reports First Quarter 2016 Financial Results and Recent Operational Progress
» Press Release | Company News

Editas Medicine
May 4, 2016 - Editas Medicine Achieves Milestone under its Collaboration with Juno Therapeutics
» Press Release | Company News

Blueprint Medicines
May 3, 2016 - Blueprint Medicines to Report First Quarter 2016 Financial Results on Tuesday, May 10, 2016
» Press Release | Company News

Foundation Medicine
May 3, 2016 - Foundation Medicine Announces 2016 First Quarter Results and Recent Highlights
» Press Release | Company News

Foundation Medicine
May 3, 2016 - Foundation Medicine Announces Commercial Launch of Liquid Biopsy Assay, FoundationACT™
» Press Release | Company News

Foundation Medicine
May 3, 2016 - Foundation Medicine and AstraZeneca Collaborate to Develop Companion Diagnostic Assays in Oncology
» Press Release | Company News

Ninepoint Medical
May 3, 2016 - NinePoint Medical Strengthens Sales Leadership by appointing John Temple as Vice President of Sales
» Press Release | Company News

Nurix, Inc.
May 3, 2016 - Nurix Announces New Appointments to its Board of Directors
» Press Release | Company News

Nurix, Inc.
May 3, 2016 - Nurix Strengthens Executive Leadership Team
» Press Release | Company News

Zafgen
May 3, 2016 - Zafgen to Host Conference Call to Discuss First Quarter 2016 Financial Results
» Press Release | Company News

Agios Pharmaceuticals
May 2, 2016 - Agios to Webcast Conference Call of First Quarter 2016 Financial Results on May 5, 2016
» Press Release | Company News

Myokardia
May 2, 2016 - MyoKardia Receives Orphan Drug Designation for MYK-461 for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
» Press Release | Company News

Eleven Biotherapeutics
April 29, 2016 - Eleven Biotherapeutics to Present Data at the ARVO 2016 Annual Meeting
» Press Release | Company News

Voyager Therapeutics
April 29, 2016 - Voyager Therapeutics Highlights Programs in Parkinson’s Disease and ALS; Announces Expansion of CNS Pipeline at R&D Day
» Press Release | Company News

Foundation Medicine
April 28, 2016 - Foundation Medicine to Present at Upcoming Investor Conferences
» Press Release | Company News

Pliant Therapeutics
April 28, 2016 - Pliant Therapeutics Expands Leadership Team
» Press Release | Company News

SAGE Therapeutics
April 28, 2016 - Sage Therapeutics to Report First Quarter 2016 Financial Results on Thursday, May 5, 2016
» Press Release | Company News

bluebird bio
April 27, 2016 - bluebird bio to Present at Two Upcoming Investor Conferences
» Press Release | Company News

Editas Medicine
April 27, 2016 - Editas Medicine to Present at Deutsche Bank 41st Annual Health Care Conference
» Press Release | Company News

Editas Medicine
April 27, 2016 - Editas Medicine Announces Presentations at Upcoming Scientific Conferences
» Press Release | Company News

CytomX Therapeutics
April 26, 2016 - CytomX to Present at the 2016 Bank of America Merrill Lynch Healthcare Conference
» Press Release | Company News

Afferent Pharmaceuticals
April 25, 2016 - Afferent Pharmaceuticals Announces Presentations of Chronic Cough Clinical Data and Hypertension Research for the Upcoming American Thoracic Society (ATS) 2016 International Conference
» Press Release | Company News

CytomX Therapeutics
April 21, 2016 - CytomX and AbbVie Announce Strategic Collaboration for Probody Drug Conjugates
» Press Release | Company News

bluebird bio
April 20, 2016 - bluebird bio Reports Interim Clinical Data from Starbeam Study of Lenti-D™ at AAN 2016 Annual Meeting
» Press Release | Company News

Constellation Pharmaceuticals
April 19, 2016 - Constellation Pharmaceuticals, Inc. To Present At The Epigenetics: Cancer and Beyond Symposium
» Press Release | Company News

Jounce Therapeutics
April 19, 2016 - Jounce Therapeutics to Deliver Keynote Address and Overview of Lead Program at PEGS Boston 2016
» Press Release | Company News

bluebird bio
April 18, 2016 - bluebird bio to Present Immuno-Oncology and Gene Therapy Data at the ASGCT 19th Annual Meeting
» Press Release | Company News

Foundation Medicine
April 18, 2016 - Foundation Medicine's Molecular Information Supports Discovery of Precision Therapeutics for Pediatric Cancers
» Press Release | Company News

Jounce Therapeutics
April 17, 2016 - Jounce Therapeutics Presents Data Highlighting Advances From Two Programs in its Immuno-Oncology Pipeline at the 2016 AACR Annual Meeting
» Press Release | Company News

SAGE Therapeutics
April 17, 2016 - Sage Therapeutics Expands Scientific, Clinical and Burden of Illness Data for SAGE-547 in SRSE and Essential Tremor at the 2016 American Academy of Neurology Annual Meeting
» Press Release | Company News

Blueprint Medicines
April 15, 2016 - Blueprint Medicines Appoints Lynn Seely, M.D. to Board of Directors
» Press Release | Company News

Voyager Therapeutics
April 14, 2016 - Voyager Therapeutics to Host R&D Day and Webcast on April 29, 2016
» Press Release | Company News

Kala Pharmaceuticals
April 13, 2016 - Kala Pharmaceuticals Announces Closing of $68 Million Series C Financing
» Press Release | Company News

Myokardia
April 13, 2016 - MyoKardia Names Mary Cranston to Board of Directors
» Press Release | Company News

Seventh Sense BioSystems
April 13, 2016 - Seventh Sense Biosystems Launches Pivotal Trial For Groundbreaking TAP Diagnostic Blood Collection Device
» Press Release | Company News

Foundation Medicine
April 7, 2016 - Foundation Medicine Announces Timing for First Quarter 2016 Financial Results and Conference Call
» Press Release | Company News

Editas Medicine
April 6, 2016 - Editas Medicine to Present at 15th Annual Needham Healthcare Conference
» Press Release | Company News

Warp Drive Bio
April 6, 2016 - Warp Drive Bio Appoints Alan C. Rigby, Ph.D., as Chief Scientific Officer
» Press Release | Company News

Blueprint Medicines
April 5, 2016 - Blueprint Medicines to Present at 15th Annual Needham Healthcare Conference
» Press Release | Company News

Constellation Pharmaceuticals
April 4, 2016 - Constellation Pharmaceuticals, Inc. To Present At The 15th Annual Needham Healthcare Conference
» Press Release | Company News

Global Blood Therapeutics
April 4, 2016 - Global Blood Therapeutics Announces Appointment of Jeffrey Farrow as CFO
» Press Release | Company News

Motus
April 4, 2016 - Motus Completes Enrollment of Phase 2b Clinical Trial of Relamorelin for Diabetic Gastroparesis
» Press Release | Company News

Motus
April 4, 2016 - Motus Presents Clinical Proof-of-Concept Results for Relamorelin in the Treatment of Anorexia
» Press Release | Company News

Zafgen
April 3, 2016 - Zafgen Presents New Data from the Phase 3 bestPWS Study Evaluating Beloranib in Prader-Willi Syndrome at ENDO 2016
» Press Release | Company News

Agios Pharmaceuticals
March 30, 2016 - Agios Announces Initiation of Phase 1/2 Frontline Combination Study of AG-221 or AG-120 with VIDAZA® (azacitidine for injection) in Newly Diagnosed Acute Myeloid Leukemia (AML) Patients Not Eligible for Intensive Chemotherapy
» Press Release | Company News

Editas Medicine
March 30, 2016 - Editas Medicine Reports Fourth Quarter and Full Year 2015 Financial Results
» Press Release | Company News

Global Blood Therapeutics
March 29, 2016 - Global Blood Therapeutics Reports Recent Business Progress and Provides Fourth Quarter and Year-End 2015 Financial Results
» Press Release | Company News

SAGE Therapeutics
March 28, 2016 - Sage Therapeutics to Present Data at the Society of Biological Psychiatry 71st Annual Scientific Meeting
» Press Release | Company News

Zafgen
March 28, 2016 - Zafgen to Present Data from bestPWS Study of Beloranib in Prader-Willi Syndrome at ENDO 2016
» Press Release | Company News

Eleven Biotherapeutics
March 24, 2016 - Eleven Biotherapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Strategic Update
» Press Release | Company News

Foundation Medicine
March 24, 2016 - New Data with FoundationOne® Supports Clinical Utility and Improved Outcomes from Molecularly Matching Non-Small Cell Lung Cancer Patients to Targeted Therapy
» Press Release | Company News

Foundation Medicine
March 23, 2016 - Foundation Medicine and Memorial Sloan Kettering Publish Validation Data for FoundationOne® Heme in the Journal Blood
» Press Release | Company News

Ablexis
March 22, 2016 - Ablexis Announces Perpetual License of the AlivaMab Mouse to a Top 15 Pharma
» Press Release | Company News

Myokardia
March 18, 2016 - MyoKardia Reports Fourth Quarter and 2015 Financial Results and Key Milestones
» Press Release | Company News

Blueprint Medicines
March 17, 2016 - Blueprint Medicines to Present Preclinical Data on RET Inhibitors in an Oral Presentation at American Association for Cancer Research Annual Meeting
» Press Release | Company News

Foundation Medicine
March 17, 2016 - Foundation Medicine Announces Presentations at the AACR Annual Meeting 2016
» Press Release | Company News

Voyager Therapeutics
March 17, 2016 - Voyager Therapeutics Provides Fourth Quarter and Full Year 2015 Investor Update
» Press Release | Company News

CytomX Therapeutics
March 16, 2016 - CytomX Announces Data to be Presented at the American Association for Cancer Research Annual Meeting 2016
» Press Release | Company News

Foundation Medicine
March 16, 2016 - Foundation Medicine Presents New Data at the 2016 USCAP Annual Meeting Underscoring Importance of Comprehensive Genomic Profiling in Cancer Care
» Press Release | Company News

Jounce Therapeutics
March 16, 2016 - Jounce Therapeutics to Present Program Updates at AACR Annual Meeting 2016
» Press Release | Company News

Blueprint Medicines
March 15, 2016 - Blueprint Medicines Announces Worldwide Collaboration to Accelerate and Expand its Development of Novel Medicines in the Field of Cancer Immunotherapy
» Press Release | Company News

Voyager Therapeutics
March 14, 2016 - Voyager Therapeutics to Present at Alliance for Regenerative Medicine’s 4th Annual Cell & Gene Therapy Investor Day
» Press Release | Company News

Blueprint Medicines
March 11, 2016 - Blueprint Medicines Reports Fourth Quarter and Full Year 2015 Financial Results
» Press Release | Company News

Voyager Therapeutics
March 10, 2016 - Voyager Therapeutics to Host Fourth Quarter and Full Year 2015 Investor Update Call
» Press Release | Company News

Zafgen
March 9, 2016 - Zafgen Reports Fourth Quarter and Full Year 2015 Financial Results
» Press Release | Company News

Zafgen
March 8, 2016 - Zafgen Adds Thomas O. Daniel, M.D. to Its Board of Directors
» Press Release | Company News

Corvia Medical
March 7, 2016 - Corvia Medical Receives IDE Approval for REDUCE LAP-HF I Clinical Study & Announces Agreement with Strategic Partner for Exclusive Option to Purchase Company
» Press Release | Company News

CytomX Therapeutics
March 7, 2016 - CytomX Announces Year-End 2015 Financial Results
» Press Release | Company News

Myokardia
March 7, 2016 - MyoKardia Names Sunil Agarwal, M.D., to Board of Directors, New VPs Strengthen Research and Development
» Press Release | Company News

Warp Drive Bio
March 7, 2016 - Warp Drive Bio to Present at the Cowen and Company 36th Annual Healthcare Conference
» Press Release | Company News

bluebird bio
March 3, 2016 - bluebird bio to Present Clinical Data on Lenti-D in CALD in Plenary Session at AAN 2016 Annual Meeting
» Press Release | Company News

CytomX Therapeutics
March 3, 2016 - CytomX to Present at Cowen and Company’s 36th Annual Health Care Conference
» Press Release | Company News

Blueprint Medicines
March 3, 2016 - Blueprint Medicines to Present at Cowen and Company 36th Annual Health Care Conference
» Press Release | Company News

SAGE Therapeutics
March 3, 2016 - Sage Therapeutics to Present SAGE-547 Clinical Data and SRSE Health Economic Data in Five Abstracts at the American Academy of Neurology 2016 Annual Meeting
» Press Release | Company News

bluebird bio
March 2, 2016 - bluebird bio to Present at Three Upcoming Investor Conferences
» Press Release | Company News

Zafgen
March 2, 2016 - Zafgen to Host Conference Call to Discuss Fourth Quarter and Full Year 2015 Financial Results
» Press Release | Company News

Allena Pharmaceuticals
March 1, 2016 - Allena Pharmaceuticals to Present at the 36th Annual Cowen and Company Health Care Conference
» Press Release | Company News

Editas Medicine
March 1, 2016 - Editas Medicine to Present at Cowen and Company 36th Annual Health Care Conference
» Press Release | Company News

Agios Pharmaceuticals
March 1, 2016 - Agios to Present at the Cowen and Company 36th Annual Health Care Conference on Tuesday, March 8
» Press Release | Company News

Myokardia
March 1, 2016 - MyoKardia to Present at Cowen and Company 36th Annual Health Care Conference
» Press Release | Company News

Zafgen
March 1, 2016 - Zafgen to Present at the Cowen & Company 36th Annual Health Care Conference
» Press Release | Company News

Foundation Medicine
February 29, 2016 - Foundation Medicine to Present at Cowen and Company's 36th Annual Healthcare Conference
» Press Release | Company News

Global Blood Therapeutics
February 29, 2016 - Global Blood Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference
» Press Release | Company News

Voyager Therapeutics
February 29, 2016 - Voyager Therapeutics to Present at Cowen and Company 36th Annual Health Care Conference
» Press Release | Company News

Zafgen
February 29, 2016 - Zafgen Joins NORD in Raising Awareness of Rare Disease Day
» Press Release | Company News

SAGE Therapeutics
February 26, 2016 - Sage Therapeutics to Present at the Cowen & Co. 36th Annual Health Care Conference
» Press Release | Company News

bluebird bio
February 25, 2016 - bluebird bio Announces Transition of Chief Financial Officer
» Press Release | Company News

Foundation Medicine
February 25, 2016 - Foundation Medicine Announces First-Ever Public Release of Broad Pediatric Data From FoundationCORE™ to Accelerate the Development of Precision Medicine Strategies for Pediatric Cancers
» Press Release | Company News

bluebird bio
February 24, 2016 - bluebird bio Reports Fourth Quarter and Full Year 2015 Financial Results and Recent Operational Progress
» Press Release | Company News

SAGE Therapeutics
February 24, 2016 - Sage Therapeutics Announces Fourth Quarter and Full Year 2015 Financial Results
» Press Release | Company News

Foundation Medicine
February 23, 2016 - Foundation Medicine Announces 2015 Fourth Quarter and Year-End Results, Recent Highlights and 2016 Outlook
» Press Release | Company News

Myokardia
February 23, 2016 - MyoKardia Announces Transition of Chief Medical Officer
» Press Release | Company News

Neon Therapeutics
February 23, 2016 - Neon Therapeutics Enters Collaborative Research Agreement with the Netherlands Cancer Institute
» Press Release | Company News

Pliant Therapeutics
February 18, 2016 - Third Rock Ventures Launches Pliant Therapeutics with $45 Million Series A to Treat Fibrotic Diseases
» Press Release | Company News

Agios Pharmaceuticals
February 18, 2016 - Agios Reports Fourth Quarter and Full Year 2015 Financial Results and Highlights Key 2016 Milestones
» Press Release | Company News

Zafgen
February 18, 2016 - Zafgen's Phase 2b Trial of Beloranib in Severe Obesity Complicated by Type 2 Diabetes Achieves Primary Efficacy Endpoint
» Press Release | Company News

bluebird bio
February 17, 2016 - bluebird bio Announces First Patient Treated with bb2121 in CRB-401 Phase 1 Study in Patients with Relapsed/Refractory Multiple Myeloma
» Press Release | Company News

Neon Therapeutics
February 17, 2016 - Neon Therapeutics Enters License Agreement with Sanquin for Peptide-MHC Assay Technology
» Press Release | Company News

SAGE Therapeutics
February 17, 2016 - Sage Therapeutics to Report Fourth Quarter and Full Year 2015 Financial Results on Wednesday, February 24, 2016
» Press Release | Company News

Blueprint Medicines
February 16, 2016 - Blueprint Medicines to Present at RBC Capital Markets 2016 Global Healthcare Conference
» Press Release | Company News

Zafgen
February 16, 2016 - Zafgen to Participate in Upcoming Investor Conferences
» Press Release | Company News

bluebird bio
February 14, 2016 - bluebird bio Reports Fourth Quarter and Full Year 2015 Financial Results and Recent Operational Progress
» Press Release | Company News

Agios Pharmaceuticals
February 11, 2016 - Agios to Webcast Conference Call of Fourth Quarter and Full Year 2015 Financial Results on February 18, 2016
» Press Release | Company News

Allena Pharmaceuticals
February 10, 2016 - Allena Pharmaceuticals Initiates Patient Treatment in Third Phase 2 Trial of ALLN-177 for Secondary Hyperoxaluria
» Press Release | Company News

Editas Medicine
February 8, 2016 - Editas Medicine Announces Closing of Initial Public Offering and Full Exercise of Option to Purchase Additional Shares
» Press Release | Company News

Global Blood Therapeutics
February 8, 2016 - Global Blood Therapeutics Announces Changes to Board of Directors
» Press Release | Company News

Blueprint Medicines
February 4, 2016 - Blueprint Medicines Appoints Lonnel Coats to Board of Directors
» Press Release | Company News

Foundation Medicine
February 4, 2016 - Foundation Medicine Announces Timing for Fourth Quarter and Year-End 2015 Financial Results and Conference Call
» Press Release | Company News

Myokardia
February 4, 2016 - MyoKardia Publishes Article in Science Demonstrating That MYK-461 Prevents and Reverses Disease in Genetic Mouse Models of Hypertrophic Cardiomyopathy
» Press Release | Company News

Agios Pharmaceuticals
February 3, 2016 - Agios to Present at the Leerink Partners 5th Annual Global Healthcare Conference on Wednesday, February 10
» Press Release | Company News

SAGE Therapeutics
February 3, 2016 - Sage Therapeutics to Present at the 2016 Leerink Global Healthcare Conference
» Press Release | Company News

Editas Medicine
February 2, 2016 - Editas Medicine Announces Pricing of Initial Public Offering
» Press Release | Company News

Foundation Medicine
February 2, 2016 - Foundation Medicine to Present at the Leerink Global Healthcare Conference
» Press Release | Company News

Voyager Therapeutics
February 2, 2016 - Voyager Therapeutics Promotes Jeff Goater to Chief Financial Officer
» Press Release | Company News

Zafgen
February 2, 2016 - Zafgen to Present at Upcoming Investor Conferences
» Press Release | Company News

Editas Medicine
January 28, 2016 - Editas Medicine Appoints John D. Mendlein, Ph.D., to Board of Directors
» Press Release | Company News

Eleven Biotherapeutics
January 26, 2016 - Albumedix and Eleven Biotherapeutics Announce Albumin Variant Technology Agreement
» Press Release | Company News

Jounce Therapeutics
January 21, 2016 - Jounce Therapeutics Appoints Perry Karsen to its Board of Directors
» Press Release | Company News

CytomX Therapeutics
January 20, 2016 - CytomX Announces Third Target Selection by Bristol-Myers Squibb, Triggering Milestone
» Press Release | Company News

Zafgen
January 20, 2016 - Zafgen's Pivotal Phase 3 Trial of Beloranib in Prader-Willi Syndrome Achieves Co-Primary Efficacy Endpoints
» Press Release | Company News

Eleven Biotherapeutics
January 15, 2016 - Eleven Biotherapeutics Reports Phase 3 Data on Isunakinra (EBI-005) in Allergic Conjunctivitis
» Press Release | Company News

Foundation Medicine
January 13, 2016 - Foundation Medicine, Horizon Healthcare Services, Inc. and COTA Collaborate to Demonstrate the Benefits of a Precision Medicine Treatment Approach for Patients with Metastatic Non-Small Cell Lung Cancer
» Press Release | Company News

Agios Pharmaceuticals
January 11, 2016 - Agios Outlines Key 2016 Goals and Priorities
» Press Release | Company News

Foundation Medicine
January 11, 2016 - Foundation Medicine Reports Preliminary 2015 Results and Provides 2016 Business Outlook, including Commercial Launch of its ctDNA Assay
» Press Release | Company News

Warp Drive Bio
January 11, 2016 - Sanofi and Warp Drive Bio to Collaborate on the Development of Novel Oncology Therapies and Antibiotics Based on Proprietary Platforms
» Press Release | Company News

Allena Pharmaceuticals
January 8, 2016 - Allena Pharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Rhythm
January 7, 2016 - Rhythm Receives Orphan Drug Designation for Setmelanotide for the Treatment of Prader-Willi Syndrome
» Press Release | Company News

Rhythm
January 7, 2016 - Rhythm Receives FDA Breakthrough Therapy Designation for Setmelanotide for Treatment of POMC Deficiency Obesity
» Press Release | Company News

Alcresta Therapeutics
January 6, 2016 - Alcresta Pharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Global Blood Therapeutics
January 6, 2016 - Global Blood Therapeutics to Present at the 34th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

SAGE Therapeutics
January 6, 2016 - Sage Therapeutics Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

bluebird bio
January 5, 2016 - bluebird bio to Present at the 34th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Blueprint Medicines
January 5, 2016 - Blueprint Medicines Strengthens Executive Leadership Team
» Press Release | Company News

Constellation Pharmaceuticals
January 5, 2016 - Constellation’s CEO Keith Dionne to present at 34th Annual J.P. Morgan Healthcare Conference in San Francisco. 7:30 am on January 11th 2016
» Press Release | Company News

Editas Medicine
January 5, 2016 - Editas Medicine Expands Leadership Team with Key Organizational Appointments
» Press Release | Company News

Foundation Medicine
January 5, 2016 - Foundation Medicine Announces Presentations at the 2016 Genitourinary Cancers Symposium
» Press Release | Company News

Rhythm
January 5, 2016 - Rhythm and Camurus Announce License Agreement for Extended Release FluidCrystal Setmelanotide
» Press Release | Company News

SAGE Therapeutics
January 5, 2016 - Sage Therapeutics Announces Proposed Public Offering of Common Stock
» Press Release | Company News

Agios Pharmaceuticals
January 4, 2016 - Agios to Present at the 34th Annual J.P. Morgan Healthcare Conference on Monday, January 11
» Press Release | Company News

Foundation Medicine
January 4, 2016 - Foundation Medicine to Present at the 34th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Global Blood Therapeutics
January 4, 2016 - Global Blood Therapeutics Appoints Scott Morrison to Board of Directors
» Press Release | Company News

SAGE Therapeutics
January 4, 2016 - Sage Therapeutics to Present at the 34th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Global Blood Therapeutics
December 31, 2015 - Global Blood Therapeutics Receives FDA Orphan Drug Designation for GBT440 in Sickle Cell Disease
» Press Release | Company News

Foundation Medicine
December 21, 2015 - Foundation Medicine And Mirati Therapeutics Collaborate To Develop A Companion Diagnostic For Glesatinib (MGCD265) In Non-Small Cell Lung Cancer (NSCLC)
» Press Release | Company News

Foundation Medicine
December 21, 2015 - Foundation Medicine Announces National Agreement with UnitedHealthcare for FoundationOne® in Metastatic Non-Small Cell Lung Cancer
» Press Release | Company News

Agios Pharmaceuticals
December 18, 2015 - Agios Announces Initiation of Phase 1b Frontline Trial of AG-221 or AG-120 in Combination with Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) Patients
» Press Release | Company News

Voyager Therapeutics
December 18, 2015 - Voyager Therapeutics Added to Russell 2000®, 3000® and Global Indexes
» Press Release | Company News

CytomX Therapeutics
December 18, 2015 - CytomX Added to Russell 2000® Index
» Press Release | Company News

Blueprint Medicines
December 17, 2015 - Blueprint Medicines Added to NASDAQ Biotechnology Index
» Press Release | Company News

Voyager Therapeutics
December 17, 2015 - Voyager Therapeutics Reports Third Quarter 2015 Financial Results
» Press Release | Company News

Rhythm
December 16, 2015 - Rhythm Appoints David Meeker, MD, and David McGirr to Board of Directors
» Press Release | Company News

Decibel Therapeutics
December 16, 2015 - Decibel Therapeutics Appoints Jeff Jonas, M.D., CEO of SAGE Therapeutics, to its Board of Directors
» Press Release | Company News

Neon Therapeutics
December 15, 2015 - Neon Therapeutics and Bristol-Myers Squibb Enter Clinical Trial Collaboration
» Press Release | Company News

SAGE Therapeutics
December 15, 2015 - SAGE Updates Guidance for Top-Line Results of Phase 3 STATUS Trial of SAGE-547
» Press Release | Company News

Blueprint Medicines
December 13, 2015 - Blueprint Medicines Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares of Common Stock
» Press Release | Company News

CytomX Therapeutics
December 11, 2015 - CytomX Selects Probody Drug Conjugate Clinical Candidate, CX-2009, Targeting Highly Expressed Tumor Antigen, CD166
» Press Release | Company News

Allena Pharmaceuticals
December 9, 2015 - Allena Pharmaceuticals Raises $53 Million in Series C Financing
» Press Release | Company News

Neon Therapeutics
December 9, 2015 - Neon Therapeutics Enters License Agreement with the Broad Institute, Dana-Farber Cancer Institute and Massachusetts General Hospital
» Press Release | Company News

Constellation Pharmaceuticals
December 9, 2015 - CONSTELLATION PHARMACEUTICALS, INC. RAISES $55 MILLION IN MEZZANINE FINANCING
» Press Release | Company News

Afferent Pharmaceuticals
December 8, 2015 - Afferent Pharmaceuticals Advances Novel Molecule, AF-130, to Phase 1 Clinical Trial
» Press Release | Company News

Foundation Medicine
December 7, 2015 - Foundation Medicine Announces Presentations at the 2015 San Antonio Breast Cancer Symposium
» Press Release | Company News

Agios Pharmaceuticals
December 6, 2015 - Agios Announces Data from Ongoing Phase 1/2 Trial of AG-221 Showing Durable Responses in Patients with Advanced Hematologic Malignancies
» Press Release | Company News

bluebird bio
December 6, 2015 - bluebird bio Reports New Beta-thalassemia Major and Severe Sickle Cell Disease Data from HGB-205 and HGB-206 Studies of LentiGlobin® at ASH Annual Meeting
» Press Release | Company News

bluebird bio
December 6, 2015 - bluebird bio Presents Pre-Clinical and Manufacturing Data from CAR T Oncology Programs at ASH Annual Meeting
» Press Release | Company News

Global Blood Therapeutics
December 6, 2015 - Global Blood Therapeutics Announces Positive Phase 1/2 Data Supporting Development of GBT440 as a Potentially Disease-Modifying Therapy for Sickle Cell Disease
» Press Release | Company News

Agios Pharmaceuticals
December 5, 2015 - Agios Announces Data from Ongoing Phase 1 Trial of AG-120 Showing Durable Responses in Patients with Advanced Hematologic Malignancies
» Press Release | Company News

bluebird bio
December 5, 2015 - bluebird bio Reports New Beta-thalassemia Major Data from Northstar Study of LentiGlobin® at ASH Annual Meeting
» Press Release | Company News

bluebird bio
December 3, 2015 - bluebird bio and ViroMed Enter into License Agreement for Novel Antibodies to Develop Chimeric Antigen Receptor T Cell Therapy
» Press Release | Company News

Alcresta Therapeutics
December 2, 2015 - Alcresta Pharmaceuticals Receives FDA Clearance for RELiZORB™
» Press Release | Company News

SAGE Therapeutics
December 2, 2015 - SAGE to Present Three Poster Presentations at the American Epilepsy Society 69th Annual Meeting
» Press Release | Company News

Zafgen
December 2, 2015 - Zafgen Provides Clinical Update on Beloranib
» Press Release | Company News

Zafgen
December 2, 2015 - Zafgen Announces Beloranib IND Placed on Complete Clinical Hold
» Press Release | Company News

Blueprint Medicines
December 1, 2015 - Blueprint Medicines and PatientCrossroads Launch Registry for Mastocytosis Patients to Increase Understanding of Disease and Speed Therapeutic Development
» Press Release | Company News

CytomX Therapeutics
December 1, 2015 - CytomX to Present at Oppenheimer's 26th Annual Healthcare Conference
» Press Release | Company News

Editas Medicine
December 1, 2015 - Editas Medicine Comments in Connection with International Summit on Human Gene Editing
» Press Release | Company News

Global Blood Therapeutics
November 30, 2015 - Global Blood Therapeutics Announces Upcoming Investor Webcasts Including Event to Highlight GBT440 Data in Sickle Cell Disease at ASH
» Press Release | Company News

bluebird bio
November 25, 2015 - bluebird bio Announces Participation in 27th Annual Piper Jaffray Healthcare Conference
» Press Release | Company News

SAGE Therapeutics
November 24, 2015 - SAGE to Present at the Piper Jaffray 27th Annual Healthcare Conference
» Press Release | Company News

CytomX Therapeutics
November 23, 2015 - CytomX Reports Third Quarter 2015 Financial Results
» Press Release | Company News

Afferent Pharmaceuticals
November 19, 2015 - Afferent Pharmaceuticals Expands Executive Leadership Team With Appointments of Prabha N. Ibrahim, PhD, as Chief Technology Officer and Michelle Carpenter, JD, RAC, as Vice President, Regulatory Affairs and Project Management
» Press Release | Company News

Jounce Therapeutics
November 17, 2015 - Jounce Therapeutics Appoints Duncan Higgons to Its Board of Directors
» Press Release | Company News

Voyager Therapeutics
November 16, 2015 - Voyager Therapeutics Announces Closing of Initial Public Offering, Including Full Exercise of Option to Purchase Additional Shares
» Press Release | Company News

Allena Pharmaceuticals
November 12, 2015 - Allena Pharmaceuticals Announces Presentation of Successful Phase 2 Data from ALLN-177 Program at American Society of Nephrology Kidney Week
» Press Release | Company News

Blueprint Medicines
November 12, 2015 - Blueprint Medicines to Present Preclinical Data at 2015 ASH Annual Meeting Demonstrating Anti-tumor Activity of BLU-285 in a Model of Acute Myeloid Leukemia
» Press Release | Company News

Foundation Medicine
November 12, 2015 - Foundation Medicine to Present at the Goldman Sachs SMID Cap Growth Conference
» Press Release | Company News

Global Blood Therapeutics
November 12, 2015 - Global Blood Therapeutics Reports Recent Business Progress and Third Quarter 2015 Financial Results
» Press Release | Company News

Afferent Pharmaceuticals
November 11, 2015 - Afferent Pharmaceuticals Announces Phase 2 Clinical Trial with AF-219 in Cough in Idiopathic Pulmonary Fibrosis (IPF) Patients
» Press Release | Company News

Global Blood Therapeutics
November 10, 2015 - Global Blood Therapeutics Announces Multiple Data Presentations Supporting GBT440 Program for Hypoxemic Pulmonary Disorders, Including Idiopathic Pulmonary Fibrosis
» Press Release | Company News

Voyager Therapeutics
November 10, 2015 - Voyager Therapeutics Announces Pricing of Initial Public Offering
» Press Release | Company News

Zafgen
November 10, 2015 - Zafgen Announces Third Quarter 2015 Financial Results
» Press Release | Company News

Blueprint Medicines
November 9, 2015 - Blueprint Medicines Reports Third Quarter 2015 Financial Results
» Press Release | Company News

Blueprint Medicines
November 9, 2015 - Blueprint Medicines Highlights Advances in Preclinical Discovery Efforts
» Press Release | Company News

Foundation Medicine
November 9, 2015 - Foundation Medicine and Collaborators to Present New Clinical Data Supporting Comprehensive Genomic Profiling in Advanced Sarcomas and Hematologic Malignancies with FoundationOne® Heme
» Press Release | Company News

Warp Drive Bio
November 9, 2015 - Warp Drive Bio Announces Breakthrough in the Ability to Target the Previously Undruggable Oncogene RAS
» Press Release | Company News

Warp Drive Bio
November 9, 2015 - Warp Drive Bio Announces Formation of Board of World-Leading Oncology Experts to Focus on Company’s RAS Program
» Press Release | Company News

Agios Pharmaceuticals
November 8, 2015 - Agios Announces Data from Dose-Escalation Phase 1 Study of AG-120 in Patients with IDH1 Mutant Positive Advanced Solid Tumors
» Press Release | Company News

CytomX Therapeutics
November 8, 2015 - CytomX Highlights Data from Multiple Probody Pipeline Programs at Investor Event During AACR-NCI-EORTC Conference
» Press Release | Company News

Rhythm
November 6, 2015 - Rhythm Presents Cardiovascular Safety Data from Phase 1b/2a Clinical Trials of Setmelanotide in Obesity
» Press Release | Company News

Rhythm
November 6, 2015 - Rhythm Presents Positive Data from Phase 1b Study of Setmelanotide for the Treatment of Genetic Obesity
» Press Release | Company News

Agios Pharmaceuticals
November 5, 2015 - Agios Reports Third Quarter 2015 Financial Results
» Press Release | Company News

Agios Pharmaceuticals
November 5, 2015 - Agios to Present New Data From Lead Programs at the 2015 ASH Annual Meeting
» Press Release | Company News

bluebird bio
November 5, 2015 - bluebird bio to present LentiGlobin® BB305 Clinical Data and bb2121 Preclinical Data at Annual Meeting of the American Society of Hematology
» Press Release | Company News

CytomX Therapeutics
November 5, 2015 - CytomX and MD Anderson Cancer Center Enter Into Strategic Collaboration for Probody-Enabled CAR-NK Cell Therapies
» Press Release | Company News

Global Blood Therapeutics
November 5, 2015 - Global Blood Therapeutics Announces New GBT440 Data in Sickle Cell Disease to be Presented at the American Society of Hematology (ASH) Annual Meeting
» Press Release | Company News

SAGE Therapeutics
November 5, 2015 - SAGE Announces Third Quarter 2015 Financial Results and Recent Pipeline Progress
» Press Release | Company News

Allena Pharmaceuticals
November 4, 2015 - Allena Pharmaceuticals To Present Phase 2 Data on ALLN-177 Program at ASN Kidney Week 2015
» Press Release | Company News

bluebird bio
November 4, 2015 - bluebird bio Announces Participation in 24th Annual Credit Suisse Healthcare Conference
» Press Release | Company News

bluebird bio
November 4, 2015 - bluebird bio Reports Third Quarter 2015 Financial Results and Recent Operational Progress
» Press Release | Company News

Eleven Biotherapeutics
November 4, 2015 - Eleven Biotherapeutics Reports Third Quarter 2015 Financial Results
» Press Release | Company News

Myokardia
November 4, 2015 - MyoKardia Announces Presentations at American Heart Association Scientific Sessions 2015
» Press Release | Company News

Agios Pharmaceuticals
November 3, 2015 - Agios to Present at Credit Suisse 24th Annual Healthcare Conference on Tuesday, November 10
» Press Release | Company News

CytomX Therapeutics
November 3, 2015 - CytomX Appoints Matthew Young to Board of Directors
» Press Release | Company News

Foundation Medicine
November 3, 2015 - Foundation Medicine Announces 2015 Third Quarter Results and Recent Highlights
» Press Release | Company News

Jounce Therapeutics
November 3, 2015 - Jounce Therapeutics Appoints Elizabeth Trehu, M.D., to Chief Medical Officer
» Press Release | Company News

Myokardia
November 3, 2015 - MyoKardia Announces Closing of Initial Public Offering
» Press Release | Company News

SAGE Therapeutics
November 3, 2015 - SAGE Announces Presentations at Upcoming November Investor Conferences
» Press Release | Company News

Zafgen
November 3, 2015 - Zafgen to Host Conference Call to Discuss Third Quarter 2015 Financial Results
» Press Release | Company News

Foundation Medicine
November 2, 2015 - Foundation Medicine Announces Roche Pharmaceuticals (Israel) Ltd. to Commence Commercial Activities in Support of its Molecular Information Products in Oncology
» Press Release | Company News

Warp Drive Bio
November 2, 2015 - Warp Drive Bio to Present First Program Using Small Molecule Assisted Receptor Targeting (SMART) Platform Against the RAS Oncogene at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
» Press Release | Company News

Agios Pharmaceuticals
October 29, 2015 - Agios to Webcast Conference Call of Third Quarter 2015 Financial Results on November 5, 2015
» Press Release | Company News

SAGE Therapeutics
October 29, 2015 - SAGE to Report Third Quarter 2015 Financial Results on Thursday, November 5, 2015
» Press Release | Company News

Igenica, Inc.
October 28, 2015 - Igenica Biotherapeutics Enters Into a Strategic Oncology Research Agreement with MedImmune
» Press Release | Company News

Myokardia
October 28, 2015 - MyoKardia Announces Pricing of Initial Public Offering
» Press Release | Company News

Eleven Biotherapeutics
October 27, 2015 - Eleven Biotherapeutics to Report Third Quarter 2015 Financial Results on November 4, 2015
» Press Release | Company News

Taris Biomedial
October 27, 2015 - TARIS Biomedical® Raises $32 Million and Expands Leadership Team and Board of Directors
» Press Release | Company News

Agios Pharmaceuticals
October 26, 2015 - Agios to Present Clinical Data from Ongoing AG-120 Phase 1 Trial in Advanced Solid Tumors at AACR-NCI-EORTC
» Press Release | Company News

CytomX Therapeutics
October 26, 2015 - Data from CytomX's Probody™ Pipeline to be Presented at the 2015 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
» Press Release | Company News

Zafgen
October 22, 2015 - Zafgen Announces Beloranib Program Update
» Press Release | Company News

bluebird bio
October 19, 2015 - bluebird bio Announces Presentation at Cooley’s Anemia Foundation Symposium
» Press Release | Company News

Agios Pharmaceuticals
October 16, 2015 - Agios Outlines Key Clinical Development & Research Strategies
» Press Release | Company News

Zafgen
October 16, 2015 - Zafgen Announces Partial Clinical Hold Affecting Beloranib Trials
» Press Release | Company News

Decibel Therapeutics
October 15, 2015 - Third Rock Ventures Launches Decibel Therapeutics with $52 Million Series A Financing to Discover New Medicines to Protect, Repair and Restore Hearing
» Press Release | Company News

Eleven Biotherapeutics
October 15, 2015 - Eleven Biotherapeutics Completes Enrollment in Pivotal Phase 3 Study of Isunakinra (EBI-005) in Patients with Allergic Conjunctivitis
» Press Release | Company News

CytomX Therapeutics
October 14, 2015 - CytomX Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
» Press Release | Company News

Global Blood Therapeutics
October 14, 2015 - Global Blood Therapeutics to Present at BIO Investor Forum
» Press Release | Company News

Myokardia
October 14, 2015 - MyoKardia Appoints Renowned Cardiovascular Medicine Expert Eric Topol, M.D., to Board of Directors
» Press Release | Company News

Zafgen
October 14, 2015 - Zafgen Issues Statement
» Press Release | Company News

Foundation Medicine
October 13, 2015 - Foundation Medicine Announces Timing for Third Quarter 2015 Financial Results and Conference Call
» Press Release | Company News

Global Blood Therapeutics
October 12, 2015 - Global Blood Therapeutics Announces GBT440 Receives FDA Fast Track Designation for Sickle Cell Disease
» Press Release | Company News

Agios Pharmaceuticals
October 8, 2015 - Agios to Webcast R&D Day on October 16, 2015
» Press Release | Company News

Alcresta Therapeutics
October 8, 2015 - Alcresta to Present at 29th Annual North American Cystic Fibrosis Conference
» Press Release | Company News

SAGE Therapeutics
October 8, 2015 - SAGE to Present Data at Upcoming Scientific Conferences
» Press Release | Company News

CytomX Therapeutics
October 7, 2015 - CytomX Announces Pricing of Initial Public Offering
» Press Release | Company News

Myokardia
October 6, 2015 - MyoKardia Provides Update on Two Phase 1 Trials of MYK-461 for the Treatment of Hypertrophic Cardiomyopathy
» Press Release | Company News

SAGE Therapeutics
October 6, 2015 - SAGE Announces Initiation of Phase 1 and First Dosing of SAGE-217
» Press Release | Company News

Jounce Therapeutics
October 1, 2015 - Jounce Therapeutics Announces Presentation at the Leerink Partners Immuno-Oncology Roundtable
» Press Release | Company News

Neon Therapeutics
October 1, 2015 - Neon Therapeutics Launches with $55 Million Series A to Develop Neoantigen-based Cancer Immunotherapies
» Press Release | Company News

Blueprint Medicines
September 30, 2015 - Blueprint Medicines Receives FDA Orphan Drug Designation for Novel Drug Candidate for Treatment of Hepatocellular Carcinoma
» Press Release | Company News

Myokardia
September 30, 2015 - FierceBiotech names MyoKardia as one of its “Fierce 15” Biotech Companies of 2015
» Press Release | Company News

REVOLUTION Medicines
September 30, 2015 - FierceBiotech Names REVOLUTION Medicines as a “Fierce 15” Biotech Company of 2015
» Press Release | Company News

Zafgen
September 30, 2015 - Zafgen Granted Orphan Drug Designation in the European Union for Beloranib, a First-in-Class MetAP2 Inhibitor for the Treatment of Craniopharyngioma
» Press Release | Company News

Afferent Pharmaceuticals
September 28, 2015 - Afferent Pharmaceuticals Announces Positive Results in Phase 2b Chronic Cough Trial
» Press Release | Company News

Zafgen
September 28, 2015 - Zafgen Announces Transition of Board of Directors
» Press Release | Company News

bluebird bio
September 24, 2015 - bluebird bio Announces Participation in Leerink Partners Immuno-Oncology Roundtable
» Press Release | Company News

Global Blood Therapeutics
September 24, 2015 - Global Blood Therapeutics Appoints Philip A. Pizzo, M.D. to Board of Directors
» Press Release | Company News

Rhythm
September 24, 2015 - FDA Office of Orphan Products Development Awards Rhythm $1 Million Grant to Support Phase 2 Study of Setmelanotide in Prader-Willi Syndrome
» Press Release | Company News

Seventh Sense BioSystems
September 24, 2015 - Seventh Sense Biosystems Announces Expansion of Manufacturing Operations and Facilities in Medford, Massachusetts
» Press Release | Company News

Zafgen
September 24, 2015 - Zafgen to Present at the Leerink Rare Disease Roundtable
» Press Release | Company News

Agios Pharmaceuticals
September 23, 2015 - Agios to Present at Leerink Partners Rare Disease Roundtable
» Press Release | Company News

SAGE Therapeutics
September 23, 2015 - SAGE Therapeutics to Participate in the 4th Annual Leerink Partners Rare Disease Roundtable
» Press Release | Company News

SAGE Therapeutics
September 21, 2015 - SAGE Therapeutics Expands Leadership Team With Key Appointments
» Press Release | Company News

Voyager Therapeutics
September 17, 2015 - Voyager Therapeutics Appoints Neuroscience Expert Steven Hyman, M.D., to Board of Directors
» Press Release | Company News

Nurix, Inc.
September 16, 2015 - Celgene and Nurix Announce Collaboration Targeting Protein Homeostasis for Next-Generation Therapies in Oncology, Inflammation and Immunology
» Press Release | Company News

Foundation Medicine
September 15, 2015 - Foundation Medicine Expands Molecular Information Decision Support Offerings with GeneKit™, a Genomic Solutions Portal for Pathologists
» Press Release | Company News

Foundation Medicine
September 15, 2015 - Foundation Medicine Launches Precision Medicine Exchange Consortium™ (PMEC) to Advance the Integration of Molecular Information in Clinical Oncology and Accelerate Adoption of Precision Care
» Press Release | Company News

Jounce Therapeutics
September 15, 2015 - Jounce Therapeutics Appoints Kim Drapkin, CPA as Chief Financial Officer
» Press Release | Company News

bluebird bio
September 11, 2015 - bluebird bio Announces Participation at Morgan Stanley Global Healthcare Conference
» Press Release | Company News

Blueprint Medicines
September 10, 2015 - Blueprint Medicines Receives FDA Authorization to Advance Novel Drug Candidate into Clinical Trial for Systemic Mastocytosis
» Press Release | Company News

Zafgen
September 10, 2015 - Zafgen to Present at Morgan Stanley Global Healthcare Conference
» Press Release | Company News

Foundation Medicine
September 9, 2015 - Foundation Medicine to Present at Morgan Stanley Global Healthcare Conference
» Press Release | Company News

Zafgen
September 9, 2015 - Zafgen Completes Enrollment of Phase 2b Trial of Beloranib in Severe Obesity Complicated by Type 2 Diabetes
» Press Release | Company News

Blueprint Medicines
September 3, 2015 - Blueprint Medicines to Present at the 22nd Annual NewsMakers in the Biotech Industry Conference
» Press Release | Company News

Global Blood Therapeutics
September 3, 2015 - Global Blood Therapeutics Announces Participation at Three September Conferences
» Press Release | Company News

SAGE Therapeutics
September 3, 2015 - SAGE Therapeutics Announces Results From Successful Exploratory Trial in Essential Tremor
» Press Release | Company News

Blueprint Medicines
September 1, 2015 - Blueprint Medicines to Present Preclinical Data on BLU-554 and on Novel Drug Target at International Liver Cancer Association 9th Annual Conference
» Press Release | Company News

Eleven Biotherapeutics
September 1, 2015 - Eleven Biotherapeutics Announces Promotions of Gary Sternberg, MD, MBA to Chief Business Officer and John McCabe, CPA to Senior Vice President, Finance
» Press Release | Company News

Eleven Biotherapeutics
August 31, 2015 - Eleven Biotherapeutics to Present at NewsMakers in the Biotech Industry Conference
» Press Release | Company News

Foundation Medicine
August 31, 2015 - Foundation Medicine to Webcast Investor & Analyst Day
» Press Release | Company News

CytomX Therapeutics
August 28, 2015 - CytomX Files Registration Statement for Proposed Initial Public Offering
» Press Release | Company News

CytomX Therapeutics
August 27, 2015 - Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer
» Press Release | Company News

Global Blood Therapeutics
August 17, 2015 - Global Blood Therapeutics Announces Closing of Initial Public Offering and Exercise of Over-Allotment Option
» Press Release | Company News

SAGE Therapeutics
August 17, 2015 - SAGE Announces First Patient Treated in Phase 3 STATUS Trial of SAGE-547 in Super-Refractory Status Epilepticus
» Press Release | Company News

Seventh Sense BioSystems
August 17, 2015 - Seventh Sense Biosystems Receives Four Patent Allowances for TAP Blood Collection System in the U.S. and Europe
» Press Release | Company News

Eleven Biotherapeutics
August 13, 2015 - Eleven Biotherapeutics Reports Second Quarter 2015 Financial Results
» Press Release | Company News

Rhythm
August 13, 2015 - Rhythm Subsidiary Raises $40 Million in Oversubscribed Financing
» Press Release | Company News

Eleven Biotherapeutics
August 12, 2015 - Eleven Biotherapeutics Announces First Patients Dosed with EBI-005 in Phase 3 Study in Patients with Moderate to Severe Allergic Conjunctivitis
» Press Release | Company News

SAGE Therapeutics
August 12, 2015 - SAGE Therapeutics Announces Second Quarter 2015 Financial Results and Highlights Recent Progress
» Press Release | Company News

Global Blood Therapeutics
August 11, 2015 - Global Blood Therapeutics Announces Pricing of Initial Public Offering
» Press Release | Company News

Blueprint Medicines
August 10, 2015 - Blueprint Medicines Reports Second Quarter 2015 Financial Results and Provides Business Update Blueprint Medicines
» Press Release | Company News

Editas Medicine
August 10, 2015 - Editas Medicine Raises $120 Million to Advance Genome Editing
» Press Release | Company News

Agios Pharmaceuticals
August 6, 2015 - Agios Reports Second Quarter 2015 Financial Results and Provides Updates on Clinical Development Progress
» Press Release | Company News

bluebird bio
August 6, 2015 - bluebird bio Reports Second Quarter 2015 Financial Results and Recent Operational Progress
» Press Release | Company News

SAGE Therapeutics
August 6, 2015 - SAGE Receives Special Protocol Assessment for Phase 3 STATUS Trial of SAGE-547 in Super-Refractory Status Epilepticus
» Press Release | Company News

Agios Pharmaceuticals
August 5, 2015 - Agios to Present at Canaccord Genuity 35th Annual Growth Conference Wednesday, August 12, 2015
» Press Release | Company News

bluebird bio
August 5, 2015 - bluebird bio Announces Participation at the 2015 Wedbush PacGrow Healthcare Conference
» Press Release | Company News

Editas Medicine
August 5, 2015 - Editas Medicine Named A 2015 Technology Pioneer by World Economic Forum
» Press Release | Company News

SAGE Therapeutics
August 5, 2015 - SAGE Therapeutics to Present at the Canaccord Genuity 35th Annual Growth Conference
» Press Release | Company News

Zafgen
August 5, 2015 - Zafgen to Present at Canaccord Genuity 35th Annual Growth Conference 2015
» Press Release | Company News

Allena Pharmaceuticals
August 4, 2015 - Allena Pharmaceuticals Initiates Phase 2b Trial of ALLN-177 for Secondary Hyperoxaluria
» Press Release | Company News

Blueprint Medicines
August 4, 2015 - Blueprint Medicines to Present at 2015 Wedbush PacGrow Healthcare Conference
» Press Release | Company News

Eleven Biotherapeutics
August 4, 2015 - Eleven Biotherapeutics to Report Second Quarter 2015 Financial Results on August 13, 2015
» Press Release | Company News

Foundation Medicine
August 4, 2015 - Foundation Medicine to Present at Wedbush PacGrow Healthcare Conference
» Press Release | Company News

Zafgen
August 4, 2015 - Zafgen to Host Conference Call to Discuss Second Quarter 2015 Financial Results
» Press Release | Company News

CytomX Therapeutics
August 3, 2015 - CytomX Announces Management Team Promotions
» Press Release | Company News

Agios Pharmaceuticals
July 30, 2015 - Agios to Webcast Conference Call of Second Quarter 2015 Financial Results on August 6, 2015
» Press Release | Company News

Foundation Medicine
July 29, 2015 - Foundation Medicine Announces 2015 Second Quarter Results and Recent Highlights
» Press Release | Company News

Foundation Medicine
July 28, 2015 - Foundation Medicine Initiates Multi-Center Clinical Study Evaluating Its Circulating Tumor DNA (ctDNA) Assay in Multiple Tumor Types
» Press Release | Company News

Alcresta Therapeutics
July 22, 2015 - Alcresta Appoints Russell Clayton, D.O., Chief Medical Officer
» Press Release | Company News

Voyager Therapeutics
July 22, 2015 - Voyager Therapeutics Appoints Michael Higgins to Board of Directors
» Press Release | Company News

Blueprint Medicines
July 13, 2015 - Blueprint Medicines Receives FDA Authorization to Proceed with Clinical Trials for Two Drug Candidates
» Press Release | Company News

Afferent Pharmaceuticals
July 8, 2015 - Afferent Pharmaceuticals Raises $55 Million in Oversubscribed Crossover Financing
» Press Release | Company News

Foundation Medicine
July 6, 2015 - Foundation Medicine Announces Timing for Second Quarter 2015 Financial Results and Conference Call
» Press Release | Company News

Editas Medicine
July 1, 2015 - Editas Medicine Appoints Andrew Hack, M.D., Ph.D., as Chief Financial Officer
» Press Release | Company News

Voyager Therapeutics
July 1, 2015 - Voyager Therapeutics Appoints Perry A. Karsen to Board of Directors
» Press Release | Company News

Blueprint Medicines
June 29, 2015 - Blueprint Medicines Added to Russell 2000®, 3000® and Global Indexes
» Press Release | Company News

Agios Pharmaceuticals
June 24, 2015 - Agios Announces First Patient Dosed with AG-881 in Phase 1 Study in Patients with Advanced Solid Tumors with an IDH Mutation
» Press Release | Company News

Eleven Biotherapeutics
June 24, 2015 - Eleven Biotherapeutics Announces Executive Change
» Press Release | Company News

Agios Pharmaceuticals
June 23, 2015 - Agios Appoints Maykin Ho, Ph.D., to its Board of Directors
» Press Release | Company News

bluebird bio
June 23, 2015 - bluebird bio Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

bluebird bio
June 23, 2015 - bluebird bio Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

bluebird bio
June 23, 2015 - bluebird bio Announces Proposed Public Offering of Common Stock
» Press Release | Company News

bluebird bio
June 22, 2015 - Kite Pharma and bluebird bio Announce Strategic Collaboration to Advance Second Generation TCR Cell Therapy Products to Treat HPV-Associated Cancers
» Press Release | Company News

Blueprint Medicines
June 22, 2015 - Blueprint Medicines Debuts Preclinical Data for First-in-Class RET Drug Candidate
» Press Release | Company News

Corvia Medical
June 22, 2015 - DC Devices Completes Enrollment In Clinical Trial of the First Transcatheter Device to Treat Diastolic Heart Failure; Announces Name Change to Corvia Medical
» Press Release | Company News

Foundation Medicine
June 22, 2015 - IMS Health and Foundation Medicine Announce Collaboration to Optimize Targeting of Precision Therapies in Oncology
» Press Release | Company News

Zafgen
June 17, 2015 - Zafgen to Present at JMP Securities Life Sciences Conference 2015
» Press Release | Company News

CytomX Therapeutics
June 16, 2015 - CytomX Raises $70 Million in Series D Financing
» Press Release | Company News

bluebird bio
June 15, 2015 - Philip Gregory, D. Phil., Joins bluebird bio as Chief Scientific Officer
» Press Release | Company News

bluebird bio
June 13, 2015 - bluebird bio Reports New Beta-thalassemia Major and Severe Sickle Cell Disease Data from HGB-205 Study at EHA
» Press Release | Company News

Agios Pharmaceuticals
June 12, 2015 - Agios Reports New, Final Data from Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers for AG-348, an Investigational Medicine for Pyruvate Kinase (PK) Deficiency
» Press Release | Company News

Agios Pharmaceuticals
June 12, 2015 - Agios Announces New Data from Ongoing Phase 1 Trial of AG-120 Showing Durable Clinical Activity in Patients with Advanced Hematologic Malignancies
» Press Release | Company News

Agios Pharmaceuticals
June 12, 2015 - Agios Announces New Data from Ongoing Phase 1 Dose Escalation and Expansion Trial of AG-221 Showing Durable Clinical Activity in Patients with Advanced Hematologic Malignancies
» Press Release | Company News

Blueprint Medicines
June 11, 2015 - Blueprint Medicines Reports First Quarter 2015 Financial Results
» Press Release | Company News

Agios Pharmaceuticals
June 10, 2015 - Agios Pharmaceuticals Announces FDA Orphan Drug Designation Granted to AG-120 for Treatment of IDH1-Mutant Positive Acute Myelogenous Leukemia
» Press Release | Company News

Zafgen
June 10, 2015 - Zafgen to Present at 2015 BIO International Convention
» Press Release | Company News

bluebird bio
June 9, 2015 - bluebird bio Completes NIH RAC Review of HGB-208 Pediatric Study Protocol
» Press Release | Company News

SAGE Therapeutics
June 9, 2015 - SAGE Therapeutics Announces Positive Top-Line Data in Exploratory Trial of SAGE-547 in Postpartum Depression
» Press Release | Company News

Blueprint Medicines
June 5, 2015 - Blueprint Medicines to Present at Upcoming Investor Conferences in June
» Press Release | Company News

Rhythm
June 4, 2015 - Rhythm Initiates Two Phase 2 Clinical Trials of Setmelanotide (RM-493) in Rare Genetic Disorders of Obesity Caused by MC4 Pathway Deficiencies
» Press Release | Company News

bluebird bio
June 3, 2015 - Celgene and bluebird bio to Develop Anti-BCMA Product Candidates; bluebird bio Regains Rights to CAR T Programs Outside of BCMA
» Press Release | Company News

SAGE Therapeutics
June 3, 2015 - SAGE Therapeutics to Participate in the Goldman Sachs 36th Annual Global Healthcare Conference
» Press Release | Company News

Foundation Medicine
June 2, 2015 - Foundation Medicine to Present at Upcoming Investor Conferences
» Press Release | Company News

Foundation Medicine
June 1, 2015 - Foundation Medicine Identifies Patients Likely to Respond to Certain MET Inhibitor Targeted Therapies; Durable Responses in Non-Small Cell Lung Cancer (NSCLC) Presented at ASCO Annual Meeting
» Press Release | Company News

REVOLUTION Medicines
June 1, 2015 - Rationally Designed Antifungal Compounds that Evade Resistance Reported in Nature Chemical Biology by Scientific Founder of REVOLUTION Medicines
» Press Release | Company News

CytomX Therapeutics
May 28, 2015 - CytomX to Present at the Jefferies 2015 Global Healthcare Conference
» Press Release | Company News

Zafgen
May 28, 2015 - Zafgen Completes Enrollment of U.S. Phase 3 Trial of Beloranib in Prader-Willi Syndrome
» Press Release | Company News

CytomX Therapeutics
May 27, 2015 - CytomX Expands Executive Leadership Team
» Press Release | Company News

Editas Medicine
May 27, 2015 - Juno Therapeutics and Editas Medicine Announce Exclusive Collaboration to Create Next-Generation CAR T and TCR Cell Therapies
» Press Release | Company News

Zafgen
May 27, 2015 - Zafgen Appoints Global Head of Medical Affairs and Global Head of Regulatory
» Press Release | Company News

bluebird bio
May 26, 2015 - bluebird bio and Five Prime Therapeutics Enter into License Agreement for Novel Antibodies to Develop Chimeric Antigen Receptor T Cell Therapy
» Press Release | Company News

bluebird bio
May 22, 2015 - bluebird bio Announces Participation at the Jefferies 2015 Global Healthcare Conference
» Press Release | Company News

Agios Pharmaceuticals
May 21, 2015 - Agios to Present Clinical and Preclinical Data at the 20th Congress of the European Hematology Association
» Press Release | Company News

bluebird bio
May 21, 2015 - bluebird bio to Present LentiGlobin Clinical Data at 20th Congress of European Hematology Association
» Press Release | Company News

bluebird bio
May 19, 2015 - bluebird bio Announces Global Regulatory Strategy for LentiGlobin BB305 in Beta-Thalassemia Major
» Press Release | Company News

Agios Pharmaceuticals
May 18, 2015 - Agios Announces FDA Fast Track Designation Granted to AG-120 for Treatment of Patients with Acute Myelogenous Leukemia with an IDH1 Mutation
» Press Release | Company News

Editas Medicine
May 18, 2015 - Editas Medicine Presents Data from Multiple Therapeutic Discovery Programs Emerging from its Genome Editing Platform at the ASGCT Annual Conference
» Press Release | Company News

Eleven Biotherapeutics
May 18, 2015 - Eleven Biotherapeutics Announces Top-Line Results from Pivotal Phase 3 Study of EBI-005 in Patients with Moderate to Severe Dry Eye Disease
» Press Release | Company News

Foundation Medicine
May 18, 2015 - Foundation Medicine and Collaborators to Present Data in 22 Oral and Poster Presentations at the 2015 ASCO Annual Meeting
» Press Release | Company News

Kala Pharmaceuticals
May 14, 2015 - Kala Pharmaceuticals Appoints Mark Iwicki as Executive Chairman
» Press Release | Company News

SAGE Therapeutics
May 14, 2015 - SAGE Therapeutics Announces SAGE-547 Progress and First Quarter 2015 Financial Results
» Press Release | Company News

SAGE Therapeutics
May 14, 2015 - SAGE Therapeutics Achieves 77 Percent Response Rate in Completed Phase 1/2 Clinical Trial of SAGE-547 in Super-Refractory Status Epilepticus
» Press Release | Company News

Foundation Medicine
May 13, 2015 - Foundation Medicine's Comprehensive Genomic Profile Informs Therapeutic Choices and Leads to Promising Outcomes in Pediatric Patients With Gliomas
» Press Release | Company News

SAGE Therapeutics
May 12, 2015 - SAGE Therapeutics to Present at UBS Global Healthcare Conference
» Press Release | Company News

Zafgen
May 12, 2015 - Zafgen Reports First Quarter 2015 Financial Results
» Press Release | Company News

Blueprint Medicines
May 11, 2015 - Blueprint Medicines Publishes Strategy for Advancing Kinase Drug Discovery
» Press Release | Company News

Foundation Medicine
May 11, 2015 - Foundation Medicine Announces 2015 First Quarter Results and Recent Highlights
» Press Release | Company News

Zafgen
May 8, 2015 - Zafgen Presents Positive Safety and Efficacy Data From Phase 2 Trial of Beloranib in Severe Obesity and Proof of Concept Trial in Prader-Willi Syndrome at ECO 2015
» Press Release | Company News

Agios Pharmaceuticals
May 7, 2015 - Agios Reports First Quarter 2015 Financial Results and Outlines Late-Stage Clinical Development for AG-221 and AG-120
» Press Release | Company News

Eleven Biotherapeutics
May 7, 2015 - Eleven Biotherapeutics Presents Clinical Data on EBI-005 for the Treatment of Dry Eye Disease and Allergic Conjunctivitis at ARVO 2015 Annual Meeting
» Press Release | Company News

SAGE Therapeutics
May 7, 2015 - SAGE Therapeutics to Report First Quarter 2015 Financial Results on Thursday, May 14
» Press Release | Company News

Zafgen
May 7, 2015 - Zafgen Announces Oral and Poster Presentations at the 22nd European Congress on Obesity
» Press Release | Company News

bluebird bio
May 6, 2015 - bluebird bio Reports First Quarter 2015 Financial Results and Business Updates
» Press Release | Company News

CytomX Therapeutics
May 6, 2015 - CytomX to Present Probody Overview at the Credit Suisse Antibody Day
» Press Release | Company News

Editas Medicine
May 6, 2015 - Editas Medicine Announces Six Scientific Presentations at the American Society of Gene And Cell Therapy 18th Annual Meeting
» Press Release | Company News

Blueprint Medicines
May 5, 2015 - Blueprint Medicines Announces Closing of Initial Public Offering
» Press Release | Company News

Eleven Biotherapeutics
May 5, 2015 - Eleven Biotherapeutics Presents Data on EBI-031 for the Treatment of Diabetic Macular Edema at ARVO 2015 Annual Meeting
» Press Release | Company News

Foundation Medicine
May 5, 2015 - Foundation Medicine to Present at Upcoming Investor Conferences
» Press Release | Company News

Jounce Therapeutics
May 5, 2015 - Jounce Therapeutics to Present at the Bank of America Merrill Lynch 2015 Health Care Conference
» Press Release | Company News

Voyager Therapeutics
May 5, 2015 - Voyager Therapeutics to Present at the American Society of Gene & Cell Therapy 18th Annual Meeting
» Press Release | Company News

Zafgen
May 5, 2015 - Zafgen to Host Conference Call to Discuss First Quarter 2015 Financial Results
» Press Release | Company News

Kala Pharmaceuticals
May 1, 2015 - Kala Pharmaceuticals to Present at the Association for Research in Vision and Ophthalmology 2015 Annual Meeting
» Press Release | Company News

bluebird bio
April 30, 2015 - bluebird bio Announces Participation at Two Upcoming Health Care Conferences
» Press Release | Company News

Eleven Biotherapeutics
April 30, 2015 - Eleven Biotherapeutics Reports First Quarter 2015 Financial Results
» Press Release | Company News

Myokardia
April 30, 2015 - MyoKardia, Inc. Completes $46 Million Series B Financing
» Press Release | Company News

Agios Pharmaceuticals
April 29, 2015 - Agios Pharmaceuticals Selects Third Novel IDH Mutant Inhibitor, AG-881, for Clinical Development
» Press Release | Company News

Blueprint Medicines
April 29, 2015 - Blueprint Medicines Announces Pricing of Initial Public Offering
» Press Release | Company News

Eleven Biotherapeutics
April 29, 2015 - Eleven Biotherapeutics Publishes Clinical Data on EBI-005 for the Treatment of Allergic Conjunctivitis
» Press Release | Company News

Agios Pharmaceuticals
April 28, 2015 - Agios Pharmaceuticals to Webcast Conference Call of First Quarter 2015 Financial Results on May 7, 2015
» Press Release | Company News

Constellation Pharmaceuticals
April 28, 2015 - Constellation Pharmaceuticals Initiates Clinical Development of CPI-1205, a Novel Inhibitor of EZH2, in Patients with Lymphoma
» Press Release | Company News

Voyager Therapeutics
April 28, 2015 - Voyager Therapeutics Promotes Jeff Goater to Senior Vice President, Finance and Business Development
» Press Release | Company News

Editas Medicine
April 27, 2015 - Vic Myer, Ph.D. Joins Editas Medicine as Chief Technology Officer
» Press Release | Company News

Blueprint Medicines
April 24, 2015 - Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression in Models of Hepatocellular Carcinoma
» Press Release | Company News

Jounce Therapeutics
April 23, 2015 - Jounce Therapeutics Secures $56 Million in Oversubscribed Series B Financing
» Press Release | Company News

Eleven Biotherapeutics
April 22, 2015 - Eleven Biotherapeutics to Present Data on Ocular Therapeutics Pipeline at the ARVO 2015 Annual Meeting
» Press Release | Company News

Eleven Biotherapeutics
April 21, 2015 - Eleven Biotherapeutics to Report First Quarter 2015 Financial Results on April 30, 2015
» Press Release | Company News

SAGE Therapeutics
April 21, 2015 - SAGE Therapeutics Announces Closing of $138 Million Public Offering of Common Stock Including Full Exercise of Option to Purchase Additional Shares
» Press Release | Company News

Foundation Medicine
April 20, 2015 - Foundation Medicine and Collaborators to Present New Data in 12 Oral and Poster Presentations at the AACR Annual Meeting
» Press Release | Company News

Foundation Medicine
April 20, 2015 - Foundation Medicine Announces Its Collaboration with the National Cancer Institute on Exceptional Responders Initiative
» Press Release | Company News

SAGE Therapeutics
April 20, 2015 - SAGE Therapeutics Announces First Patient Treated Under Phase 3 Expanded Access Protocol to Evaluate SAGE-547 in Patients With Super-Refractory Status Epilepticus
» Press Release | Company News

Allena Pharmaceuticals
April 16, 2015 - Allena Pharmaceuticals Appoints Louis Brenner, M.D. as Chief Operating Officer
» Press Release | Company News

Kala Pharmaceuticals
April 16, 2015 - Kala Pharmaceuticals Presents at the Ophthalmology Innovation Summit
» Press Release | Company News

Jounce Therapeutics
April 15, 2015 - Jounce Therapeutics to Present at the Jefferies 2015 Immuno-Oncology Summit
» Press Release | Company News

Foundation Medicine
April 14, 2015 - Foundation Medicine Announces Timing for First Quarter 2015 Financial Results and Conference Call
» Press Release | Company News

Global Blood Therapeutics
April 14, 2015 - Global Blood Therapeutics Appoints New Chief Business and Strategy Officer
» Press Release | Company News

SAGE Therapeutics
April 14, 2015 - SAGE Therapeutics Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

CytomX Therapeutics
April 13, 2015 - CytomX to Present Overview of Precision Cancer Immunotherapies at the Jefferies Immuno-Oncology Summit
» Press Release | Company News

SAGE Therapeutics
April 13, 2015 - SAGE Therapeutics Announces Proposed Public Offering of Common Stock
» Press Release | Company News

Voyager Therapeutics
April 13, 2015 - Voyager Therapeutics Raises $60 Million in Oversubscribed Series B Financing
» Press Release | Company News

REVOLUTION Medicines
April 9, 2015 - REVOLUTION Medicines Appoints Pharmaceutical Commercial Executive Elizabeth McKee Anderson to Board of Directors
» Press Release | Company News

SAGE Therapeutics
April 9, 2015 - SAGE Therapeutics Announces Presentations at Upcoming Scientific Conferences
» Press Release | Company News

Blueprint Medicines
April 8, 2015 - Blueprint Medicines to Present New Preclinical Data on BLU-285 in Treatment-Resistant GIST and on Novel Cancer Drug Targets at Upcoming AACR Annual Meeting
» Press Release | Company News

Rhythm
April 8, 2015 - Rhythm Initiates Phase 2b Clinical Trial of Relamorelin for Diabetic Gastroparesis
» Press Release | Company News

Motus
April 8, 2015 - Rhythm Initiates Phase 2b Clinical Trial of Relamorelin for Diabetic Gastroparesis
» Press Release | Company News

Foundation Medicine
April 7, 2015 - Foundation Medicine and Roche Complete Strategic Transaction to Advance Molecular Information and Precision Medicine in Oncology
» Press Release | Company News

Foundation Medicine
April 2, 2015 - Foundation Medicine Stockholders Approve Pending Roche Transaction at Special Meeting of Stockholders
» Press Release | Company News

Global Blood Therapeutics
April 2, 2015 - Global Blood Therapeutics Appoints Two New Board Members
» Press Release | Company News

SAGE Therapeutics
April 2, 2015 - SAGE Therapeutics Announces Positive End-of-Phase 2 Meeting With FDA and Planned Initiation of SAGE-547 Global Phase 3 Trial in Mid-2015
» Press Release | Company News

Kala Pharmaceuticals
April 1, 2015 - Kala Pharmaceuticals Announces Positive Results from Phase 3 Trial of KPI-121 in Cataract Surgery
» Press Release | Company News

Kala Pharmaceuticals
April 1, 2015 - Kala Pharmaceuticals Announces Positive Results from Phase 2 Trial of KPI-121 in Dry Eye Disease
» Press Release | Company News

Agios Pharmaceuticals
March 24, 2015 - Agios Pharmaceuticals Announces Orphan Drug Designation of AG-348 for Treatment of Pyruvate Kinase Deficiency
» Press Release | Company News

Blueprint Medicines
March 23, 2015 - Blueprint Medicines Appoints Charles A. Rowland, Jr. to its Board of Directors
» Press Release | Company News

Foundation Medicine
March 23, 2015 - Foundation Medicine and Collaborators to Present New Data in 20 Oral and Poster Presentations at the 2015 USCAP Annual Meeting
» Press Release | Company News

Foundation Medicine
March 23, 2015 - Foundation Medicine Announces Executive Promotions and Expanded Leadership Team to Complement Global Growth Initiatives
» Press Release | Company News

Foundation Medicine
March 23, 2015 - Foundation Medicine Announces Proposed Changes to its Board of Directors in Connection with the Pending Roche Transaction
» Press Release | Company News

Zafgen
March 19, 2015 - Zafgen Reports Fourth Quarter and Full Year 2014 Financial Results
» Press Release | Company News

Allena Pharmaceuticals
March 18, 2015 - Allena Pharmaceuticals Announces Positive Phase 2a Data of ALLN-177 for the Treatment of Hyperoxaluria
» Press Release | Company News

bluebird bio
March 18, 2015 - bluebird bio to Present at Alliance for Regenerative Medicine’s 3rd Annual Regen Med Investor Day
» Press Release | Company News

CytomX Therapeutics
March 18, 2015 - CytomX Appoints Immuno-Oncology Leader Rachel Humphrey, M.D., to Board of Directors
» Press Release | Company News

Blueprint Medicines
March 16, 2015 - Blueprint Medicines Publishes Preclinical Proof-of-Concept Data on Promising New Therapy for Patients with Genomically Defined Hepatocellular Carcinoma
» Press Release | Company News

REVOLUTION Medicines
March 12, 2015 - Major Advances in Synthetic Chemistry Reported in Science by Founding Scientist of REVOLUTION Medicines
» Press Release | Company News

Zafgen
March 12, 2015 - Zafgen to Host Conference Call to Discuss Fourth Quarter and Full Year 2014 Financial Results
» Press Release | Company News

Zafgen
March 7, 2015 - Zafgen Announces New Weight Loss and Safety Data from Phase 2 Trial of Beloranib in Hypothalamic Injury Associated Obesity at ENDO 2015
» Press Release | Company News

REVOLUTION Medicines
March 5, 2015 - REVOLUTION Medicines Expands Executive Leadership Team
» Press Release | Company News

Eleven Biotherapeutics
March 4, 2015 - Eleven Biotherapeutics Reports Fourth Quarter and Year-End 2014 Financial Results
» Press Release | Company News

Warp Drive Bio
March 4, 2015 - Warp Drive Bio Appoints Industry Veteran Laurence Reid, Ph.D., to Chief Executive Officer
» Press Release | Company News

Blueprint Medicines
March 3, 2015 - Blueprint Medicines Announces Strategic Collaboration with Alexion to Advance Kinase Drug Candidates in Rare Genetic Disease
» Press Release | Company News

Myokardia
March 3, 2015 - MyoKardia Announces Initiation of Phase 1 Clinical Study of MYK-461 for Hypertrophic Cardiomyopathy
» Press Release | Company News

Editas Medicine
March 2, 2015 - Editas Medicine Reports New Data Demonstrating Potential of CRISPR/Cas9 Construct as Novel Gene Repair Mechanism
» Press Release | Company News

CytomX Therapeutics
March 2, 2015 - CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates
» Press Release | Company News

SAGE Therapeutics
February 27, 2015 - SAGE Therapeutics Reports Fourth Quarter and Full Year 2014 Financial Results
» Press Release | Company News

Zafgen
February 27, 2015 - Zafgen Joins NORD to Support Rare Disease Day(R)
» Press Release | Company News

CytomX Therapeutics
February 26, 2015 - CytomX to Present at Cowen and Company 35th Annual Health Care Conference
» Press Release | Company News

Zafgen
February 26, 2015 - Zafgen to Present at Cowen and Company 35th Annual Health Care Conference
» Press Release | Company News

Afferent Pharmaceuticals
February 26, 2015 - Afferent Clinical Data for Lead Candidate, AF-219, Demonstrate Improvements in Pain and Urinary Urgency in Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)
» Press Release | Company News

bluebird bio
February 25, 2015 - bluebird bio Reports Fourth Quarter and Full Year 2014 Financial Results and Recent Operational Progress
» Press Release | Company News

Foundation Medicine
February 25, 2015 - Foundation Medicine to Present at Upcoming Investor Conferences
» Press Release | Company News

Jounce Therapeutics
February 25, 2015 - Jounce Therapeutics to Present at the Cowen and Company 35th Annual Health Care Conference
» Press Release | Company News

bluebird bio
February 24, 2015 - bluebird bio Announces Participation in Upcoming Investor Conferences
» Press Release | Company News

Eleven Biotherapeutics
February 24, 2015 - Eleven Biotherapeutics to Present at Cowen & Company 35th Annual Health Care Conference
» Press Release | Company News

Foundation Medicine
February 24, 2015 - Foundation Medicine Announces 2014 Fourth Quarter and Year-End Results, Recent Highlights and 2015 Outlook
» Press Release | Company News

Eleven Biotherapeutics
February 23, 2015 - Eleven Biotherapeutics to Report Fourth Quarter and Full Year 2014 Financial Results on March 4, 2015
» Press Release | Company News

Foundation Medicine
February 23, 2015 - Foundation Medicine and H3 Biomedicine Announce Collaboration to Develop Precision Therapies for Cancer
» Press Release | Company News

Agios Pharmaceuticals
February 20, 2015 - Agios Pharmaceuticals to Present at Cowen and Company 35th Annual Health Care Conference on Monday, March 2
» Press Release | Company News

Voyager Therapeutics
February 20, 2015 - Voyager Therapeutics to Present at Cowen and Company 35th Annual Health Care Conference
» Press Release | Company News

Foundation Medicine
February 19, 2015 - Foundation Medicine to Present New Clinical Data on Clinical Applications of FoundationOne® at the 16th Annual Advances in Genome Biology and Technology Meeting
» Press Release | Company News

Zafgen
February 18, 2015 - Zafgen to Present at the 2015 RBC Capital Markets Conference
» Press Release | Company News

Agios Pharmaceuticals
February 17, 2015 - Agios Pharmaceuticals Reports Fourth Quarter and Full Year 2014 Financial Results
» Press Release | Company News

SAGE Therapeutics
February 13, 2015 - SAGE Therapeutics Appoints New Vice Presidents to Lead Key Organizational Functions
» Press Release | Company News

Foundation Medicine
February 12, 2015 - New Data from FoundationOne® Demonstrates Genomic Basis for Potential New Routes to Therapy and Improved Outcomes for Individuals with Cancers of Unknown Primary
» Press Release | Company News

Voyager Therapeutics
February 11, 2015 - Voyager Therapeutics & Genzyme Announce Major Strategic Collaboration to Develop and Commercialize Novel AAV Gene Therapies for Patients with CNS Disorders
» Press Release | Company News

Blueprint Medicines
February 11, 2015 - Blueprint Medicines Appoints Anthony Boral, M.D., Ph.D., as Senior Vice President, Clinical Development
» Press Release | Company News

Agios Pharmaceuticals
February 10, 2015 - Agios Pharmaceuticals to Webcast Conference Call of Fourth Quarter and Full Year 2014 Financial Results on February 17, 2015
» Press Release | Company News

Global Blood Therapeutics
February 10, 2015 - Global Blood Therapeutics Strengthens Management Team with Addition of Vice President of Program Leadership and Business Strategy
» Press Release | Company News

bluebird bio
February 5, 2015 - bluebird bio to Present at the Leerink Global Healthcare Conference
» Press Release | Company News

Global Blood Therapeutics
February 5, 2015 - Global Blood Therapeutics to Present at 17th Annual BIO CEO & Investor Conference
» Press Release | Company News

REVOLUTION Medicines
February 4, 2015 - Third Rock Ventures Launches REVOLUTION Medicines with $45 Million Series A to Redesign Evolution’s Products to Treat Serious Diseases
» Press Release | Company News

Foundation Medicine
February 4, 2015 - Foundation Medicine to Present at the Leerink Global Healthcare Conference
» Press Release | Company News

Agios Pharmaceuticals
February 3, 2015 - Agios Pharmaceuticals to Present at the 2015 Leerink Global Healthcare Conference on Wednesday, February 11
» Press Release | Company News

Foundation Medicine
February 3, 2015 - Foundation Medicine Announces Timing for Fourth Quarter and Year-End 2014 Financial Results and Conference Call
» Press Release | Company News

bluebird bio
February 2, 2015 - FDA Grants Breakthrough Therapy Designation to LentiGlobin for Treatment of Beta-Thalassemia Major
» Press Release | Company News

bluebird bio
January 29, 2015 - bluebird bio Announces Transition of Chief Scientific Officer
» Press Release | Company News

Eleven Biotherapeutics
January 29, 2015 - Eleven Biotherapeutics to Present at Upcoming Investor Conferences in February
» Press Release | Company News

SAGE Therapeutics
January 28, 2015 - SAGE Therapeutics Announces Participation in February Conferences
» Press Release | Company News

Zafgen
January 28, 2015 - Zafgen Announces Closing of Public Offering of Common Stock and Full-Exercise of Option to Purchase Additional Shares
» Press Release | Company News

Eleven Biotherapeutics
January 22, 2015 - Eleven Biotherapeutics Appoints Barry Gertz, MD, PhD, and Jay S. Duker, MD, to Board of Directors
» Press Release | Company News

Zafgen
January 22, 2015 - Zafgen Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

Foundation Medicine
January 12, 2015 - Foundation Medicine Enters a Broad, Strategic Collaboration with Roche in the Field of Molecular Information in Oncology
» Press Release | Company News

Agios Pharmaceuticals
January 12, 2015 - Agios Announces that Celgene Has Agreed to Exercise its Option to License AG-120 under Global Strategic
» Press Release | Company News

Editas Medicine
January 12, 2015 - Editas Medicine Reports New Data Characterizing Novel Properties of Staphylococcus aureus Cas9 as a Tool for CRISPR-Based Genome Engineering
» Press Release | Company News

Foundation Medicine
January 12, 2015 - Foundation Medicine Reports Preliminary 2014 Results
» Press Release | Company News

Global Blood Therapeutics
January 12, 2015 - Global Blood Therapeutics Announces First Cohort Dosed in Phase I/II Trial of GBT440 in Sickle Cell Disease
» Press Release | Company News

SAGE Therapeutics
January 12, 2015 - SAGE Therapeutics Initiates Phase 2a Trial of SAGE-547 in Postpartum Depression
» Press Release | Company News

Foundation Medicine
January 9, 2015 - FoundationOne® Identifies High Frequency of Clinically Relevant Genomic Alterations (GA) Previously Missed by Conventional Genomic Tests, Enabling Successful Targeted Treatment in Patients with Non-Small Cell Lung Cancer
» Press Release | Company News

SAGE Therapeutics
January 9, 2015 - SAGE Therapeutics Reports Updated Data From Ongoing Clinical Trial and Emergency Use Program of SAGE-547 in Patients With Super-Refractory Status Epilepticus
» Press Release | Company News

Allena Pharmaceuticals
January 8, 2015 - Allena Pharmaceuticals to Present at 2015 J.P. Morgan Healthcare Conference
» Press Release | Company News

Blueprint Medicines
January 8, 2015 - Blueprint Medicines to Present at the 33rd Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Foundation Medicine
January 8, 2015 - Foundation Medicine and Collaborators to Present New Clinical Data on the Application of FoundationOne® at the 2015 Gastrointestinal Cancers Symposium
» Press Release | Company News

Global Blood Therapeutics
January 8, 2015 - Willie L. Brown, Jr. Joins the Board of Directors of Global Blood Therapeutics
» Press Release | Company News

Jounce Therapeutics
January 8, 2015 - Jounce Therapeutics Appoints Deborah Law, D. Phil., to Chief Scientific Officer
» Press Release | Company News

Foundation Medicine
January 7, 2015 - Foundation Medicine Launches ICE 2, Its New Version of Interactive Cancer Explorer, Featuring PatientMatch
» Press Release | Company News

Zafgen
January 7, 2015 - Zafgen Announces Positive Results From Phase 2 Clinical Trial of Beloranib in Hypothalamic Injury Associated Obesity
» Press Release | Company News

bluebird bio
January 6, 2015 - bluebird bio to Present at the 33rd Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

CytomX Therapeutics
January 6, 2015 - CytomX Raises $20 Million in Series C Round Led by Pfizer Venture Investments
» Press Release | Company News

Foundation Medicine
January 6, 2015 - Foundation Medicine to Present at the J.P. Morgan Healthcare Conference
» Press Release | Company News

Global Blood Therapeutics
January 6, 2015 - Global Blood Therapeutics Completes $48 Million Series B Financing
» Press Release | Company News

Jounce Therapeutics
January 6, 2015 - Jounce Therapeutics to Present at the J.P. Morgan Healthcare Conference
» Press Release | Company News

Myokardia
January 6, 2015 - MyoKardia to Present at the 33rd Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Agios Pharmaceuticals
January 5, 2015 - Agios Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference on Monday, January 12
» Press Release | Company News

CytomX Therapeutics
January 5, 2015 - CytomX Expands Leadership Team with Addition of Michael Kavanaugh, M.D., as Chief Scientific Officer and Head of Research and Early Development
» Press Release | Company News

Global Blood Therapeutics
January 5, 2015 - Global Blood Therapeutics to Present at Upcoming Investor Conferences
» Press Release | Company News

SAGE Therapeutics
January 5, 2015 - SAGE Therapeutics to Present at 33rd Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

SAGE Therapeutics
December 17, 2014 - SAGE Therapeutics Added to NASDAQ Biotechnology Index
» Press Release | Company News

Agios Pharmaceuticals
December 16, 2014 - Agios Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Over-Allotment Option
» Press Release | Company News

Foundation Medicine
December 16, 2014 - Foundation Medicine to Be Added to NASDAQ Biotechnology Index
» Press Release | Company News

Zafgen
December 16, 2014 - Zafgen Added to NASDAQ Biotechnology Index
» Press Release | Company News

bluebird bio
December 15, 2014 - bluebird bio Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

Zafgen
December 15, 2014 - Zafgen Announces Initiation of Phase 2b Trial of Beloranib in Severe Obesity
» Press Release | Company News

Rhythm
December 11, 2014 - Rhythm Appoints Fred T. Fiedorek, M.D., Chief Medical Officer
» Press Release | Company News

Voyager Therapeutics
December 11, 2014 - Voyager Therapeutics and MassBiologics Announce Strategic Collaboration for Viral Vector Manufacturing
» Press Release | Company News

Agios Pharmaceuticals
December 10, 2014 - Agios Pharmaceuticals Announces Pricing of $220 Million Public Offering of Common Stock
» Press Release | Company News

Agios Pharmaceuticals
December 9, 2014 - Agios Pharmaceuticals Announces Proposed Offering of Common Stock
» Press Release | Company News

Agios Pharmaceuticals
December 9, 2014 - Agios Pharmaceuticals Appoints Kaye Foster-Cheek to its Board of Directors
» Press Release | Company News

Foundation Medicine
December 9, 2014 - New Clinical Data Supports the Use of FoundationOne® Heme to Enable Informed Treatment Decisions in a Wide Range of Hematologic Malignancies
» Press Release | Company News

Foundation Medicine
December 9, 2014 - FoundationOne® Identifies Clinically Relevant Genomic Alterations in Patients with Advanced Breast Cancers
» Press Release | Company News

Foundation Medicine
December 8, 2014 - Treatment for Relapsed Multiple Myeloma Patients Guided by FoundationOne® Heme Results in Promising Clinical Activity
» Press Release | Company News

Agios Pharmaceuticals
December 8, 2014 - Agios Announces Celgene Decision to Extend Discovery Phase of Global Strategic Collaboration to April 2016
» Press Release | Company News

Agios Pharmaceuticals
December 8, 2014 - Agios Reports Positive Phase 1 Data in Healthy Volunteers for AG-348, a First-in-Class Investigational Medicine That Targets the Underlying Cause of Pyruvate Kinase (PK) Deficiency
» Press Release | Company News

Global Blood Therapeutics
December 8, 2014 - Global Blood Therapeutics’ GBT440 Demonstrates Ability to Positively Impact Fundamental Sickle Cell Disease (SCD) Processes in Studies Presented at 2014 American Society of Hematology (ASH) Conference
» Press Release | Company News

bluebird bio
December 8, 2014 - bluebird bio Announces Data Demonstrating First Four Patients with β-Thalassemia Major Treated with LentiGlobin™ are Transfusion-Free
» Press Release | Company News

Blueprint Medicines
December 8, 2014 - Blueprint Medicines Debuts Comprehensive Preclinical Data Set on First Selective Drug for Patients with Systemic Mastocytosis at 2014 American Society of Hematology Annual Meeting
» Press Release | Company News

Agios Pharmaceuticals
December 7, 2014 - Agios Announces New Data from Ongoing Phase 1 Trial of AG-221 Showing Robust Clinical Activity in Patients with Advanced Hematologic Malignancies
» Press Release | Company News

Ablexis
December 4, 2014 - Ablexis Announces Availability of the AlivaMab Mouse Technology and Settlement of the Litigation with Regeneron Pharmaceuticals, Inc.
» Press Release | Company News

Allena Pharmaceuticals
December 4, 2014 - Allena Pharmaceuticals Secures $25 Million Series B Financing
» Press Release | Company News

Ninepoint Medical
December 4, 2014 - NinePoint Medical Appoints Christopher von Jako, Ph.D., to Chief Executive Officer
» Press Release | Company News

Afferent Pharmaceuticals
December 3, 2014 - Afferent Pharmaceuticals Announces the Election of Dr. Peter Hirth to the Company’s Board of Directors
» Press Release | Company News

Foundation Medicine
December 3, 2014 - Foundation Medicine and Collaborators to Present New Clinical Data on the Application of FoundationOne® in Breast Cancer at the 2014 San Antonio Breast Cancer Symposium
» Press Release | Company News

Foundation Medicine
December 2, 2014 - Foundation Medicine Appoints David J. Daly as Chief Commercial Officer
» Press Release | Company News

Foundation Medicine
December 2, 2014 - Foundation Medicine and Flatiron Health Collaborate to Develop First-in-Class Data Platform to Accelerate Precision Medicine for Cancer
» Press Release | Company News

Global Blood Therapeutics
December 2, 2014 - Global Blood Therapeutics to Present New Data Highlighting Therapeutic Potential of GBT440 in Sickle Cell Disease (SCD) at 2014 American Society of Hematology (ASH) Conference
» Press Release | Company News

Nurix, Inc.
December 2, 2014 - Nurix Launches Collaboration with Mount Sinai Hospital’s Lunenfeld-Tanenbaum Research Institute to Expand its Drug Discovery Program
» Press Release | Company News

Editas Medicine
December 1, 2014 - Editas Medicine Licenses Genome Editing Technology from Broad Institute and Harvard University
» Press Release | Company News

Editas Medicine
December 1, 2014 - Editas Medicine Licenses Genome Editing Technology from Massachusetts General Hospital
» Press Release | Company News

Eleven Biotherapeutics
November 26, 2014 - Eleven Biotherapeutics to Present at Oppenheimer 25th Annual Healthcare Conference
» Press Release | Company News

Afferent Pharmaceuticals
November 25, 2014 - Afferent Clinical Data Demonstrating AF-219 Treatment Reduces Cough Frequency by 75% in Chronic Cough Is Published in The Lancet
» Press Release | Company News

Eleven Biotherapeutics
November 25, 2014 - Eleven Biotherapeutics Announces Additional Financing of $20 Million
» Press Release | Company News

Foundation Medicine
November 25, 2014 - Foundation Medicine to Present at the Piper Jaffray Healthcare Conference
» Press Release | Company News

Blueprint Medicines
November 20, 2014 - Blueprint Medicines Unveils New Drug Discovery Program for Patients with RET Fusions at 26th EORTC-NCI-AACR Symposium
» Press Release | Company News

Foundation Medicine
November 19, 2014 - Foundation Medicine's Novel Companion Diagnostic Test, Developed in Collaboration with Clovis Oncology, Identifies Expanded Subgroup of Cancer Patients with the Potential to Respond to Clovis Oncology's PARP inhibitor, Rucaparib
» Press Release | Company News

Agios Pharmaceuticals
November 18, 2014 - Agios Pharmaceuticals Announces Early Phase 1 Data Showing Clinical Activity of AG-120 as a Single Agent in Advanced Acute Myeloid Leukemia (AML)
» Press Release | Company News

Blueprint Medicines
November 13, 2014 - Blueprint Medicines to Present Discovery of New Cancer Drug Targets at EORTC-NCI-AACR Symposium
» Press Release | Company News

Eleven Biotherapeutics
November 13, 2014 - Eleven Biotherapeutics Reports Third Quarter 2014 Financial Results
» Press Release | Company News

Foundation Medicine
November 13, 2014 - Foundation Medicine to Present at Upcoming Investor Conferences
» Press Release | Company News

bluebird bio
November 12, 2014 - bluebird bio Reports Fiscal Third Quarter 2014 Financial Results
» Press Release | Company News

Blueprint Medicines
November 12, 2014 - Blueprint Medicines Secures $50 Million in Series C Financing
» Press Release | Company News

Foundation Medicine
November 12, 2014 - The Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Northwestern Medicine Developmental Therapeutics Institute Partner with Foundation Medicine to Launch Innovative Clinical Translation Program
» Press Release | Company News

SAGE Therapeutics
November 11, 2014 - SAGE Therapeutics Reports Third Quarter 2014 Results
» Press Release | Company News

Zafgen
November 11, 2014 - Zafgen Reports Third Quarter 2014 Financial Results
» Press Release | Company News

Allena Pharmaceuticals
November 10, 2014 - Allena Pharmaceuticals To Present Data on Lead Program ALLN-177 at ASN Kidney Week 2014
» Press Release | Company News

bluebird bio
November 10, 2014 - James M. DeTore joins bluebird bio as Chief Financial Officer
» Press Release | Company News

SAGE Therapeutics
November 10, 2014 - SAGE Therapeutics Reports Positive Top-Line Phase 2 Data of SAGE-547 in Patients With Super-Refractory Status Epilepticus
» Press Release | Company News

Agios Pharmaceuticals
November 7, 2014 - Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results
» Press Release | Company News

bluebird bio
November 7, 2014 - bluebird bio to Present at Three Upcoming Health Care Conferences
» Press Release | Company News

SAGE Therapeutics
November 7, 2014 - SAGE Therapeutics Announces Six Scientific Presentations at Neuroscience 2014, the Society for Neuroscience's 44th Annual Meeting
» Press Release | Company News

Agios Pharmaceuticals
November 6, 2014 - Agios Pharmaceuticals to Present Clinical and Preclinical Data at the 2014 American Society of Hematology Annual Meeting
» Press Release | Company News

bluebird bio
November 6, 2014 - bluebird bio to Present LentiGlobin Clinical Data at the American Society of Hematology Conference
» Press Release | Company News

Foundation Medicine
November 6, 2014 - Foundation Medicine and Collaborators to Present New Clinical Data on FoundationOne® Heme at the American Society of Hematology Annual Meeting
» Press Release | Company News

Foundation Medicine
November 5, 2014 - Foundation Medicine Announces 2014 Third Quarter Results and Recent Highlights
» Press Release | Company News

SAGE Therapeutics
November 5, 2014 - SAGE to Present at Credit Suisse 23rd Annual Healthcare Conference
» Press Release | Company News

Eleven Biotherapeutics
November 4, 2014 - Eleven Biotherapeutics to Report Third Quarter 2014 Financial Results on November 13, 2014
» Press Release | Company News

Foundation Medicine
November 4, 2014 - Foundation Medicine Signs Data Partnership with Cancer Outcomes Tracking and Analysis (COTA, Inc.) to Inform Value-Based Cancer Treatment
» Press Release | Company News

Eleven Biotherapeutics
November 3, 2014 - Eleven Biotherapeutics Completes Enrollment in Pivotal Phase 3 Study of EBI-005 in Patients with Dry Eye Disease
» Press Release | Company News

Foundation Medicine
November 3, 2014 - Foundation Medicine Partners with EmergingMed to Offer Clinical Trial Navigation Services for Physicians and Patients
» Press Release | Company News

SAGE Therapeutics
November 3, 2014 - First Evaluation of SAGE-547 to Treat Super-Refractory Status Epilepticus in Children Published in Annals of Neurology
» Press Release | Company News

Agios Pharmaceuticals
October 27, 2014 - Agios Pharmaceuticals to Webcast Conference Call of Third Quarter 2014 Financial Results on November 7, 2014
» Press Release | Company News

Rhythm
October 24, 2014 - Rhythm Presents Positive Phase 2 Study Results for Relamorelin for Chronic Constipation
» Press Release | Company News

Alcresta Therapeutics
October 23, 2014 - Alcresta Presents New Data Demonstrating Potential of Proprietary Enzyme-Based Technology to Improve Nutrition in Patients with Exocrine Pancreatic Insufficiency
» Press Release | Company News

Eleven Biotherapeutics
October 23, 2014 - Eleven Biotherapeutics Appoints Wendy L. Dixon, PhD to Board of Directors
» Press Release | Company News

Igenica, Inc.
October 23, 2014 - Igenica Biotherapeutics to Present New Data on Proprietary SNAP Antibody Drug Conjugate Technology at Upcoming World ADC Summit
» Press Release | Company News

SAGE Therapeutics
October 23, 2014 - SAGE Therapeutics Initiates Exploratory Study of SAGE-547 in Essential Tremor
» Press Release | Company News

Foundation Medicine
October 22, 2014 - Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China
» Press Release | Company News

Rhythm
October 22, 2014 - Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin
» Press Release | Company News

Agios Pharmaceuticals
October 21, 2014 - Agios Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of AG-221 in Patients with Advanced Solid Tumors with an IDH2 Mutation
» Press Release | Company News

Voyager Therapeutics
October 21, 2014 - Voyager Therapeutics Commemorates Opening of New Headquarters
» Press Release | Company News

Foundation Medicine
October 16, 2014 - Priority Health is First Health Plan to Cover FoundationOne® and FoundationOne® Heme to Enhance Precision Cancer Treatment
» Press Release | Company News

Foundation Medicine
October 16, 2014 - Foundation Medicine Announces Timing for Third Quarter 2014 Financial Results and Conference Call
» Press Release | Company News

Agios Pharmaceuticals
October 15, 2014 - Agios Pharmaceuticals Announces Initiation of Four Expansion Cohorts in Phase 1 Study of AG-221
» Press Release | Company News

bluebird bio
October 14, 2014 - bluebird bio Announces First Patient with Sickle Cell Disease Transplanted with LentiGlobin Gene Therapy
» Press Release | Company News

Blueprint Medicines
October 14, 2014 - Blueprint Medicines to Present at JMP Securities Life Sciences Private Company Conference
» Press Release | Company News

Constellation Pharmaceuticals
October 9, 2014 - Constellation meets contractual milestones and receives balance of $15 million loan
» Press Release | Company News

Eleven Biotherapeutics
October 7, 2014 - Eleven Biotherapeutics Granted U.S. Composition-of-Matter Patent for EBI-005
» Press Release | Company News

Agios Pharmaceuticals
October 6, 2014 - Agios Pharmaceuticals to Webcast R&D Day on October 15, 2014
» Press Release | Company News

Eleven Biotherapeutics
October 2, 2014 - Eleven Biotherapeutics Announces Top-Line Results from Phase 2 Study of EBI-005 in Patients with Moderate to Severe Allergic Conjunctivitis
» Press Release | Company News

Zafgen
October 1, 2014 - Zafgen Announces Initiation of Phase 3 Trial of Beloranib in Prader-Willi Syndrome
» Press Release | Company News

Blueprint Medicines
September 30, 2014 - Blueprint Medicines to Present at 13th Annual BIO Investor Forum
» Press Release | Company News

Agios Pharmaceuticals
September 26, 2014 - Agios Pharmaceuticals to Present Clinical Data from AG-120 Ongoing Phase 1 Study in Hematologic Malignancies at EORTC-NCI-AACR 2014
» Press Release | Company News

SAGE Therapeutics
September 25, 2014 - SAGE Therapeutics to Participate in the 2014 Leerink Partners Rare Disease Roundtable
» Press Release | Company News

Zafgen
September 25, 2014 - Zafgen Completes Enrollment of Phase 2a Trial of Beloranib in Hypothalamic Injury-Associated Obesity
» Press Release | Company News

Zafgen
September 24, 2014 - Zafgen to Present at 2014 Leerink Partners Rare Disease Roundtable
» Press Release | Company News

Agios Pharmaceuticals
September 23, 2014 - Agios Pharmaceuticals to Present at the 2014 Leerink Partners Rare Disease Roundtable
» Press Release | Company News

Editas Medicine
September 22, 2014 - FierceBiotech names Editas Medicine as one of its Fierce 15 Biotech Companies of 2014
» Press Release | Company News

Voyager Therapeutics
September 22, 2014 - FierceBiotech Names Voyager Therapeutics as one of its “Fierce 15” Biotech Companies of 2014
» Press Release | Company News

Blueprint Medicines
September 19, 2014 - First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines
» Press Release | Company News

Nurix, Inc.
September 18, 2014 - Nurix, Inc. Names Arthur T. Sands, M.D., Ph.D., Chief Executive Officer
» Press Release | Company News

Zafgen
September 18, 2014 - Frances K. Heller Rejoins Zafgen Board of Directors
» Press Release | Company News

Myokardia
September 17, 2014 - Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease
» Press Release | Company News

SAGE Therapeutics
September 16, 2014 - SAGE Therapeutics Appoints Michael F. Cola to the Company's Board of Directors
» Press Release | Company News

Afferent Pharmaceuticals
September 10, 2014 - Afferent Pharmaceuticals Names Kathleen Sereda Glaub as Chief Executive Officer
» Press Release | Company News

Blueprint Medicines
September 10, 2014 - Blueprint Medicines Discovers Novel Cancer Drug Targets
» Press Release | Company News

Blueprint Medicines
September 9, 2014 - Blueprint Medicines to Participate in Morgan Stanley Global Healthcare Conference 2014
» Press Release | Company News

Blueprint Medicines
September 8, 2014 - Blueprint Medicines Presents Positive Data on BLU-554 for Hepatocellular Carcinoma
» Press Release | Company News

Voyager Therapeutics
September 3, 2014 - Voyager Therapeutics Appoints Steven Paul, M.D., to Chief Executive Officer
» Press Release | Company News

Foundation Medicine
September 3, 2014 - Foundation Medicine to Present at the Morgan Stanley Global Healthcare Conference
» Press Release | Company News

SAGE Therapeutics
September 2, 2014 - SAGE Therapeutics Presents New Preclinical Data on SAGE-217 at Eilat Conference on New Anti-Epileptic Drugs
» Press Release | Company News

Eleven Biotherapeutics
August 28, 2014 - Eleven Biotherapeutics to Participate in Upcoming Investor Conferences in September
» Press Release | Company News

Rhythm
August 27, 2014 - Rhythm Files Registration Statement for Proposed Initial Public Offering
» Press Release | Company News

SAGE Therapeutics
August 14, 2014 - SAGE Therapeutics Reports Second Quarter 2014 Financial Results
» Press Release | Company News

Agios Pharmaceuticals
August 13, 2014 - Agios Pharmaceuticals Announces the U.S. FDA Grants Fast Track Designation to AG-221 for Treatment of Patients With Acute Myelogenous Leukemia That Harbor an IDH2 Mutation
» Press Release | Company News

Eleven Biotherapeutics
August 13, 2014 - Eleven Biotherapeutics Reports Second Quarter 2014 Financial Results
» Press Release | Company News

Seventh Sense BioSystems
August 13, 2014 - Seventh Sense Biosystems Closes $16 Million Series B Financing
» Press Release | Company News

Taris Biomedial
August 13, 2014 - Allergan Acquires LiRIS® Program from TARIS Biomedical®
» Press Release | Company News

Zafgen
August 13, 2014 - Zafgen Reports Second Quarter 2014 Financial Results
» Press Release | Company News

bluebird bio
August 12, 2014 - bluebird bio Reports Fiscal Second Quarter 2014 Financial Results
» Press Release | Company News

Foundation Medicine
August 12, 2014 - Foundation Medicine Announces 2014 Second Quarter Results and Recent Highlights
» Press Release | Company News

Foundation Medicine
August 12, 2014 - Foundation Medicine to Present at the Wedbush 2014 Life Sciences Conference
» Press Release | Company News

Zafgen
August 11, 2014 - Zafgen to Present at 34th Annual Canaccord Genuity Growth Conference
» Press Release | Company News

Agios Pharmaceuticals
August 7, 2014 - Agios Pharmaceuticals Reports Second Quarter 2014 Financial Results
» Press Release | Company News

Foundation Medicine
August 7, 2014 - Foundation Medicine Appoints Lisa Ricciardi Senior Vice President, Corporate and Business Development
» Press Release | Company News

Igenica, Inc.
August 7, 2014 - Igenica Biotherapeutics Awarded SBIR Grant for Next Generation Antibody Drug Conjugate Technology
» Press Release | Company News

SAGE Therapeutics
August 7, 2014 - SAGE Therapeutics to Present at Canaccord Genuity 34th Annual Growth Conference
» Press Release | Company News

Zafgen
August 7, 2014 - Zafgen to Host Conference Call to Discuss Second Quarter 2014 Financial Results
» Press Release | Company News

Blueprint Medicines
August 6, 2014 - Blueprint Medicines to Present at Wedbush 2014 Life Sciences Management Access Conference
» Press Release | Company News

bluebird bio
August 5, 2014 - bluebird bio to Present at Two Upcoming Health Care Conferences
» Press Release | Company News

Constellation Pharmaceuticals
August 4, 2014 - Constellation Expands Clinical Studies of CPI-0610
» Press Release | Company News

Global Blood Therapeutics
August 4, 2014 - Global Blood Therapeutics Names Hing Sham Senior Vice President of Chemistry, Promotes Uma Sinha to Chief Scientific Officer
» Press Release | Company News

Eleven Biotherapeutics
August 1, 2014 - Eleven Biotherapeutics to Report Second Quarter 2014 Financial Results on August 13, 2014
» Press Release | Company News

Voyager Therapeutics
August 1, 2014 - Dinah Sah, Senior Vice President of Neuroscience and Rob Kotin, Vice President of Production Honored Among PharmaVOICE 100 Most Inspiring People
» Press Release | Company News

Kala Pharmaceuticals
July 31, 2014 - Kala Pharmaceuticals Initiates Phase 2 Clinical Trial to Evaluate LE-MPP (KPI-121) in Patients with Retinal Vein Occlusion and Diabetic Macular Edema
» Press Release | Company News

Foundation Medicine
July 29, 2014 - Foundation Medicine Releases Enhanced Version of FoundationOne®
» Press Release | Company News

Eleven Biotherapeutics
July 29, 2014 - Eleven Biotherapeutics to Present at Wedbush 2014 Life Sciences Management Access Conference
» Press Release | Company News

Agios Pharmaceuticals
July 28, 2014 - Agios Pharmaceuticals to Webcast Conference Call of Second Quarter 2014 Financial Results on August 7, 2014
» Press Release | Company News

Blueprint Medicines
July 24, 2014 - Blueprint Medicines Appoints Jeffrey Albers as Chief Executive Officer
» Press Release | Company News

Foundation Medicine
July 23, 2014 - Foundation Medicine Partners with the Addario Lung Cancer Medical Institute for Innovative Prospective Study Linking the Genomic Drivers of Lung Cancer in Young Adults with Treatment Options
» Press Release | Company News

SAGE Therapeutics
July 23, 2014 - SAGE Therapeutics Announces Closing of Initial Public Offering
» Press Release | Company News

SAGE Therapeutics
July 22, 2014 - SAGE Therapeutics Receives Fast Track Designation for Lead Compound SAGE-547 to Treat Status Epilepticus
» Press Release | Company News

SAGE Therapeutics
July 21, 2014 - SAGE Therapeutics Announces Full Exercise of Over-Allotment Option
» Press Release | Company News

Foundation Medicine
July 17, 2014 - Foundation Medicine Receives Approvals from New York State Department of Health for FoundationOne® and FoundationOne Heme®
» Press Release | Company News

SAGE Therapeutics
July 17, 2014 - SAGE Therapeutics Announces Pricing of Initial Public Offering
» Press Release | Company News

bluebird bio
July 16, 2014 - bluebird bio Appoints Mark Vachon to its Board of Directors
» Press Release | Company News

Foundation Medicine
July 16, 2014 - Foundation Medicine Announces Timing for Second Quarter 2014 Financial Results and Conference Call
» Press Release | Company News

Zafgen
July 10, 2014 - Zafgen Granted Orphan Drug Designation in the European Union for Beloranib, a first-in-class METAP2 Inhibitor for the Treatment of Prader-willi Syndrome
» Press Release | Company News

Jounce Therapeutics
July 10, 2014 - Jounce Therapeutics Appoints Richard Murray, Ph.D., to Chief Executive Officer
» Press Release | Company News

bluebird bio
July 8, 2014 - bluebird bio Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

bluebird bio
July 7, 2014 - bluebird bio Announces Proposed Public Offering of Common Stock
» Press Release | Company News

Corvia Medical
July 1, 2014 - DC Devices Closes $34M Series D Financing to Complete Clinical Evaluation of the First Transcatheter Device to Treat Diastolic Heart Failure
» Press Release | Company News

bluebird bio
June 30, 2014 - bluebird bio Acquires Precision Genome Engineering, a Privately Held Gene-Editing Company
» Press Release | Company News

Foundation Medicine
June 26, 2014 - Foundation Medicine Offers FoundationOne® CareLine to Provide Personalized Assistance to Cancer Patients Seeking Access to Targeted Therapies
» Press Release | Company News

Voyager Therapeutics
June 26, 2014 - Voyager Therapeutics Appoints Industry Veteran Robert G. Pietrusko, Pharm.D., to Senior Vice President of Regulatory Affairs
» Press Release | Company News

Zafgen
June 26, 2014 - Zafgen Appoints New Member of Board of Directors
» Press Release | Company News

Zafgen
June 24, 2014 - Zafgen, Inc. Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option
» Press Release | Company News

Editas Medicine
June 24, 2014 - Editas Medicine Appoints Katrine S. Bosley to Chief Executive Officer
» Press Release | Company News

Rhythm
June 23, 2014 - Rhythm Presents Clinical Data that RM-493 Increases Energy Expenditure in Obesity Study
» Press Release | Company News

Blueprint Medicines
June 20, 2014 - Blueprint Medicines to Present at JMP Securities Healthcare Conference
» Press Release | Company News

Kala Pharmaceuticals
June 19, 2014 - Kala Pharmaceuticals Initiates Phase 3 Clinical Trial for Treatment of Post-Surgical Ocular Inflammation and Phase 2 Clinical Trial in Dry Eye Disease
» Press Release | Company News

Global Blood Therapeutics
June 17, 2014 - Global Blood Therapeutics Names Ted W. Love as CEO
» Press Release | Company News

Foundation Medicine
June 16, 2014 - Groundbreaking Collaborative Clinical Trial Launched
» Press Release | Company News

Agios Pharmaceuticals
June 16, 2014 - Agios Pharmaceuticals Announces Orphan Drug Designation of AG-221 for Treatment of Acute Myelogenous Leukemia
» Press Release | Company News

Agios Pharmaceuticals
June 14, 2014 - New Agios Clinical Data from Ongoing Phase 1 Trial of AG-221 Continue to Show Complete and Durable Remissions in Patients with Difficult to Treat Hematologic Malignancies
» Press Release | Company News

bluebird bio
June 14, 2014 - bluebird bio Reports Rapid Transfusion Independence in Beta-Thalassemia Major Patients Treated with its LentiGlobin Product Candidate
» Press Release | Company News

Agios Pharmaceuticals
June 13, 2014 - Agios Pharmaceuticals Announces that Celgene Exercised its Option to License AG-221 Under Global Strategic Collaboration
» Press Release | Company News

Ninepoint Medical
June 12, 2014 - NinePoint Medical Receives 2014 MDEA Silver Medal for NvisionVLE Imaging System Deficiency, a Rare, Hemolytic Anemia
» Press Release | Company News

SAGE Therapeutics
June 10, 2014 - SAGE Therapeutics Appoints James M. Frates to the Company’s Board of Directors
» Press Release | Company News

Agios Pharmaceuticals
June 9, 2014 - Agios Pharmaceuticals Initiates Multiple Ascending Dose Trial in Healthy Volunteers of AG-348 for the Potential Treatment of PK
» Press Release | Company News

bluebird bio
June 9, 2014 - bluebird bio to Host a Conference Call to Discuss Initial Results from the HGB-205 Study in Beta-Thalassemia Major Subjects
» Press Release | Company News

SAGE Therapeutics
June 5, 2014 - SAGE Therapeutics Presents Preliminary SAGE-547 Clinical Data at Epilepsy Pipeline Conference
» Press Release | Company News

CytomX Therapeutics
May 27, 2014 - Bristol-Myers Squibb and CytomX Therapeutics Announce Worldwide Collaboration to Develop Probody™ Therapeutics Against Multiple Immuno-Oncology Targets
» Press Release | Company News

Nurix, Inc.
May 22, 2014 - Third Rock Ventures and The Column Group Launch Nurix with $25.1 Million Financing to Target Key Regulatory Pathway
» Press Release | Company News

Agios Pharmaceuticals
May 8, 2014 - Agios Pharmaceuticals Reports First Quarter 2014 Financial Results
» Press Release | Company News

Foundation Medicine
May 7, 2014 - Foundation Medicine Announces 2014 First Quarter Results and Recent Highlights
» Press Release | Company News

Eleven Biotherapeutics
May 7, 2014 - Eleven Biotherapeutics to Report First Quarter 2014 Financial Results on May 15, 2014
» Press Release | Company News

Eleven Biotherapeutics
May 6, 2014 - Eleven Biotherapeutics Presents Data on Novel Protein Therapeutics for Treatment of Front and Back of Eye Diseases at ARVO 2014 Annual Meeting
» Press Release | Company News

Foundation Medicine
May 6, 2014 - Foundation Medicine to Present at the Bank of America Merrill Lynch 2014 Healthcare Conference
» Press Release | Company News

Rhythm
May 6, 2014 - Rhythm Presents Positive Phase 2 Study Results for Ghrelin Prokinetic Relamorelin (RM-131) in Diabetic Gastroparesis
» Press Release | Company News

Rhythm
May 6, 2014 - Rhythm Presents Positive GI Motility Results for Relamorelin (RM-131) in Phase 2 Chronic Constipation Study
» Press Release | Company News

SAGE Therapeutics
May 5, 2014 - SAGE Therapeutics Appoints Thomas D. Anderson as Chief Commercial Strategy Office
» Press Release | Company News

Eleven Biotherapeutics
May 5, 2014 - Eleven Biotherapeutics Appoints Gary Sternberg, M.D., M.B.A., as Executive Vice President Corporate and Business Development
» Press Release | Company News

SAGE Therapeutics
May 1, 2014 - SAGE Therapeutics Receives U.S. Orphan Drug Designation for Lead Compound SAGE-547 to Treat Status Epilepticus
» Press Release | Company News

bluebird bio
May 1, 2014 - bluebird bio to Present at Three Upcoming Health Care Conferences
» Press Release | Company News

Agios Pharmaceuticals
April 30, 2014 - Agios Pharmaceuticals to Webcast Conference Call of First Quarter 2014 Financial Results on May 8, 2014
» Press Release | Company News

Allena Pharmaceuticals
April 29, 2014 - Allena Pharmaceuticals Announces Positive Phase 1 Data of ALLN-177 for the Treatment of Kidney Stones
» Press Release | Company News

Kala Pharmaceuticals
April 28, 2014 - New Preclinical Data Demonstrate Kala Pharmaceuticals’ Topical LE-MPP Provides Equal or Better Drug Exposure Compared to Lotemax®
» Press Release | Company News

Ninepoint Medical
April 28, 2014 - New Clinical Data using the NvisionVLE™ Imaging System to be presented at Digestive Disease Week® 2014
» Press Release | Company News

Editas Medicine
April 25, 2014 - Editas Medicine Co-founders Present Novel Methods for Improving Genome Editing Specificity in Two Nature Biotechnology Papers
» Press Release | Company News

Agios Pharmaceuticals
April 17, 2014 - Agios Initiates Phase 1 Study of AG-348, a First-in-class PKR Activator, for Pyruvate Kinase Deficiency
» Press Release | Company News

Alcresta Therapeutics
April 17, 2014 - Alcresta Announces Agreement with Cystic Fibrosis Foundation Therapeutics to Develop Point-of-Care Nutritional Products
» Press Release | Company News

Foundation Medicine
April 16, 2014 - Foundation Medicine Announces Timing for First Quarter 2014 Financial Results and Conference Call
» Press Release | Company News

PanOptica
April 15, 2014 - PanOptica Raises $45 Million to Finance Clinical Development of Anti-VEGF Eye Drop for Wet AMD
» Press Release | Company News

Blueprint Medicines
April 7, 2014 - Blueprint Medicines Presents Positive Data on First Selective FGFR4 Inhibitor
» Press Release | Company News

Agios Pharmaceuticals
April 6, 2014 - Agios Announces Initial Phase 1 Data Demonstrating Clinical Activity of AG-221, First-in-Class Inhibitor of IDH2 Mutations, in Patients with Advanced Blood Cancers
» Press Release | Company News

Foundation Medicine
April 3, 2014 - Foundation Medicine and Clovis Oncology Expand Collaboration to Develop Novel Companion Diagnostic for Rucaparib in Ovarian Cancer
» Press Release | Company News

Constellation Pharmaceuticals
April 2, 2014 - Constellation Pharmaceuticals will give a presentation on EZH2 and exhibit posters on EZH2 and BET at the AACR Annual Meeting, April 5-9 in San Diego, CA.
» Press Release | Company News

Foundation Medicine
April 1, 2014 - Foundation Medicine Announces New Data Highlighting FoundationOne™ and FoundationOne™ Heme to be Presented at the AACR Annual Meeting 2014
» Press Release | Company News

Eleven Biotherapeutics
April 1, 2014 - Eleven Biotherapeutics Added to Russell Indexes on March 31, 2014
» Press Release | Company News

SAGE Therapeutics
April 1, 2014 - SAGE Therapeutics Appoints Howard H. Pien to the Company’s Board of Directors
» Press Release | Company News

SAGE Therapeutics
March 27, 2014 - SAGE Therapeutics Initiates Phase 1/2 Trial of SAGE-547 in Status Epilepticus
» Press Release | Company News